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ABSTRACT 
MEGHAN E. JONES: The role of hippocampal neural immune signaling in stress-enhanced 
fear learning: Implications for post-traumatic stress disorder. 
(Under the direction of Donald T. Lysle) 
 
Psychopathology and disease states involving depression and anxiety, including post-
traumatic stress disorder (PTSD), have been associated with immune dysregulation. 
Preliminary data from our laboratory has suggested that severe stress induces a time-dependent 
increase in hippocampal IL-1β immunoreactivity and that centrally blocking IL-1 signaling 
prevented the development of stress-enhanced fear learning, a rodent PTSD-like phenotype. In 
parallel, astrocyte-derived cytokines and astroglial signaling have been linked to the 
development of PTSD-like phenotypes following severe stress. The goal of the current 
dissertation was to use the stress-enhanced fear learning paradigm to explore the role of neural 
immune signaling in the development of a PTSD-like phenotype. The experiments described 
in the current dissertation tested the overarching hypothesis that (1) severe stress induces 
changes in hippocampal astrocyte-derived IL-1β expression and the morphometric properties 
of hippocampal astrocytes and (2) that both blocking hippocampal IL-1 signaling and 
activating hippocampal astroglial Gi signaling prevent the development of SEFL.  
Experiments described in Chapter 2 confirm the hypothesis that hippocampal IL-1 
signaling is required for the development of SEFL and reveal astrocytes as the predominant 
cellular source of hippocampal IL-1β. Additional analyses in Chapter 2 revealed that severe 
stress induces a reduction in ionized calcium-binding adaptor molecule 1 (Iba-1) 
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immunoreactivity, with no effect on glial fibrillary acidic protein (GFAP) immunoreactivity. 
Experiments described in Chapter 3 demonstrate that there is no change in hippocampal 
astrocyte volume, surface area, or colocalization with a synaptic marker, postsynaptic density 
95 (PSD95), 48 hours post-stress. However, there was a significant stress-induced reduction in 
PSD95 immunoreactivity. Finally, experiments described in Chapter 4 show that astroglial Gi 
activation was sufficient to attenuate SEFL and provide the first direct evidence to support the 
validity of GFAP-hM4Di in that we detected a CNO-induced reduction in the colocalization 
between virus-positive cells and cyclic adenosine monophosphate (cAMP), a Gi-dependent 
second messenger. Collectively, these data suggest that hippocampal astrocytes are critically 
involved in SEFL and identify two signaling pathways that can be targeted to attenuate the 
development of a PTSD-like phenotype. This work suggests that neural immune signaling 
represents a promising target for the development of novel therapeutics to treat PTSD and 
provides insight to inform future endeavors to better understand the neurobiological 
mechanisms driving the acquisition and encoding of fear memories. 
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Chapter 1 
GENERAL INTRODUCTION 
Post-Traumatic Stress Disorder 
Post-traumatic stress disorder (PTSD) is a complex and devastating mental disorder 
with a myriad of psychological and physiological consequences (Gill, Saligan et al. 2009; Xia, 
Zhai et al. 2013).  PTSD occurs in 15-20% of people who experience a severe threat to 
psychological or physical bodily integrity ((Hoskins, Pearce et al. 2015), Diagnostics and 
Statistical Manual of Mental Disorders, 5th edition). The three hallmark symptoms of the 
disorder are intrusive memories or re-experiencing of the trauma, avoidance, and hyperarousal 
(Hoskins, Pearce et al. 2015). These symptoms manifest in many different forms with affected 
individuals exhibiting constant intrusions of unwanted traumatic memories, dissociation from 
friends and family, heightened anxiety, hypervigilance –including a hyperreactivity to future 
stressful events—and significant alterations in mood or cognition. PTSD is also associated 
with physiological changes, including both neuroimmune and neuroendocrine dysregulation 
(Gill, Saligan et al. 2009; Xia, Zhai et al. 2013).  Furthermore, significant comorbidity between 
PTSD and substance abuse, depression, and generalized anxiety disorder amplify the emotional 
and fiscal costs of the disorder on society (Hoskins, Pearce et al. 2015). There are many at-risk 
populations including active military personnel, emergency responders, cancer patients, 
victims of natural disasters or accidents, and abused individuals (e.g.,(Bowler, Han et al. 2010; 
Thomas, Wilk et al. 2010)). 
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Operations Iraqi Freedom and Enduring Freedom deployed about 2.5 million troops, 
approximately 13%-20% of which have developed PTSD (Hoge, Castro et al. 2004).  
Most treatment options for individuals with PTSD involve cognitive behavioral 
therapy, re-exposure therapy, and/or the prescription of traditional antidepressants or 
antianxiety medications (De Jongh, Resick et al. 2016). There are currently no effective 
pharmacological treatments for PTSD specifically and the ones in current use in this context 
have small effects with unclear clinical relevance (Hoskins, Pearce et al. 2015).  For example, 
while current pharmaceuticals used may improve mood or general anxiety temporarily, most 
do not improve symptoms of intrusions or dissociation (Byrne, Krystal et al. 2017). A better 
understanding of the neurobiological mechanisms driving PTSD is crucial for the development 
of more targeted pharmaceutical treatments.  
Interestingly, clinical studies have suggested that morphine treatment following a 
combat injury is associated with a significant reduction in PTSD rates among combat veterans 
(Holbrook, Galarneau et al. 2010; Melcer, Walker et al. 2014). A similar correlation was found 
in children who experienced a single-incident trauma that required an emergency room visit 
(Nixon, Nehmy et al. 2010). While a prophylactic pharmaceutical treatment for PTSD would 
be an extremely important clinical tool, the only way to work towards a better understanding 
of PTSD and to test the efficacy of and determine the mechanism through which morphine or 
any pharmacological treatment might act to treat PTSD is to rely on rodent models of the 
disorder.  
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Approaches to study Post-Traumatic Stress Disorder using rodent models 
Psychiatric disorders, including PTSD, are multi-faceted and involve complex changes 
to cognition and mood. As such, PTSD can be difficult to thoroughly capture using rodent 
models. With the introduction of the Research Domain Criteria (RDoC) framework, the 
National Institute of Mental Health (NIMH) calls for researchers to approach mental health 
research by studying distinct behavioral constructs within mental disorders on a full continuum 
of adaptive to maladaptive behavior through multiple levels of analysis.  In this way, 
researchers will uncover specific mechanisms involved in many aspects of a given disorder. 
The Research Domain Criteria framework defines behavioral constructs and subconstructs 
within five systems. Our approach to study PTSD is consistent with this organization in that 
the rodent paradigm used by our laboratory involves threat response constructs within the 
Negative Valence system defined by the NIMH, as described below.  
There are several rodent models of the disorder, all of which focus primarily on the 
hyperarousal symptom cluster, which involves both acute threat mechanisms (enhanced fear 
learning) and potential threat mechanisms (enhanced generalized anxiety-like behavior). The 
Predator Scent Stress (Kozlovsky, Matar et al. 2009; Cohen, Kozlovsky et al. 2012) and Single 
Prolonged Stress (Yamamoto, Morinobu et al. 2009) models expose rats to a severe stressor, 
soiled cat litter or a single exposure to a series of three stressors (restraint stress, forced swim, 
and ether anesthesia), respectively, and test for enhanced anxiety-like behavior in the Elevated 
Plus Maze (EPM) and Acoustic Startle Response Test (ASR) seven days later. Researchers 
then categorize rats as extreme, moderate, or low responders with the extreme category 
(highest generalized anxiety) taken to reflect a PTSD-like phenotype. However, stress-
enhanced fear learning (SEFL) models (Rau, DeCola et al. 2005; Blouin, Sillivan et al. 2016) 
4 
 
excellently demonstrate hypervigilance or hyperreactivity to future fear learning, a key 
component of human PTSD, with impressive experimental control and measurement. The 
studies in the current dissertation take advantage of the SEFL model.  
In our hands, SEFL is based on foot shock-induced contextual fear conditioning. Figure 
1.1 shows the basic experimental design for this paradigm in our laboratory. Briefly, animals 
are exposed a novel context distinct in olfactory, tactile, and auditory cues from the home cage 
(Context A) where they receive 15 2 mA scrambled foot shocks on a 6 minute variable interval 
schedule. Control animals are exposed to the context without foot shocks being delivered. One 
week later, all animals are exposed to a distinctly different context, distinct in olfactory, tactile, 
and auditory cues from both the home cage and Context A, (Context B) where they receive a 
single 1 mA scrambled foot shock. Animals who received severe foot shock stress in Context 
A show significantly enhanced (maladaptive) fear learning to Context B. Critically, prior to 
the single foot shock in Context B, animals are exposed to Context B without foot shock 
exposure for a habituation session and to test for generalization of fear between the two 
contexts. Animals do not show fear to Context B prior to the single shock. Thus, any 
differences observed between treatment groups reflect altered learning to the subsequent single 
foot shock. In other words, the severe stressor in Context A changes the way that the animals 
process the subsequent fear challenge in Context B. This model has been shown to produce 
pronounced SEFL that is robust and reliable (Rau, DeCola et al. 2005; Szczytkowski-
Thomson, Lebonville et al. 2013; Jones, Lebonville et al. 2015).   
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Figure 1.1 Stress-enhanced fear learning. In the SEFL paradigm in our laboratory,  rats are 
exposed to 15 2 mA foot shocks in Context A. Six days later, animals are exposed to Context 
B without foot shocks to test for generalization of fear between the two contexts. On Day 7, 
rats are placed back into Context B where they receive a single 1 mA foot shock. Contextual 
fear learning to Context B is then analyzed.  SEFL is used to study how the initial severe 
stressor in Context A enhances contextual fear learning to the single foot shock in Context B. 
This phenomenon reflects the hypervigilance or hyperreactivity to future stressors that is a key 
component of human PTSD.   
 
To further strengthen the use of SEFL as a model through which to study PTSD, we 
have shown that the severe stressor in SEFL (15 foot shocks in Context A) induces a 
generalized heightened anxiety-like phenotype in the elevated plus maze seven days post-stress 
(Figure 1.2),  similar to predator scent stress and single prolonged stress. Thus, while 
behavioral outcomes in the current studies focused exclusively on enhanced fear learning, the 
severe stressor of the SEFL paradigm is capable of inducing a PTSD like phenotype in rats in 
two dimensions of the Negative Valence construct within the NIMH Research Domain Criteria 
framework. Therefore, characterizing stress-induced cellular and molecular changes in the 
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brain following the severe stressor of SEFL will be important for understanding multiple 
behavioral outcomes. Converging mechanisms that drive depressive- and anxiety-like 
phenotypes that are part of the PTSD-like phenotype as a whole will be important in our overall 
understanding of behavioral outcomes following stress that lead to PTSD.  
 
 
 
 
 
Figure 1.2 Stressor of the SEFL paradigm enhances general anxiety-like behavior seven 
days later. In order to compare the behavioral consequences of severe foot shock in SEFL to 
the behavioral consequences of stress in the predator scent stress and single prolonged stress 
models, rats were exposed to foot shock stress in Context A (15 2 mA scrambled foot shocks 
over 90 minutes) and then returned to their home cage for six days. Seven days after foot shock 
stress, animals were tested for anxiety-like behavior in the Elevated Plus Maze. Rats exposed 
to foot shock stress exhibited less time in the open arms of the maze (left panel) and a greater 
number of stretched attend postures (right panel, a measure of risk assessment behavior), both 
of which are reflective of enhanced anxiety in the model. * p < 0.05. 
 
Interestingly, using the SEFL model, our laboratory provided the first basic animal 
research support for the use of morphine as a prophylactic treatment for PTSD. Morphine 
treatment following exposure to severe foot shock stress attenuated the development of SEFL 
(Szczytkowski-Thomson, Lebonville et al. 2013). Specifically, acute morphine treatment at 48 
hours after, but not immediately after, severe stress attenuated SEFL. This finding provides 
important rationale to support the value of the studies in the current dissertation because any 
effect of morphine on pain treatment would be most potent immediately following foot shock. 
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Thus, these results suggest that morphine treatment exerts its effect on behavioral outcomes 
following stress through a unique neural mechanism that drives enhanced fear learning.   
While it is exciting that the use of morphine has shown promise to clinically prevent or 
alleviate PTSD, its use clinically in this context is severely limited by its abuse liability. 
Further, high co-morbidity between opioid abuse specifically and PTSD in a number of settings 
presents additional problems to its use as treatment (Fareed, Eilender et al. 2013; Dabbs, 
Watkins et al. 2014). The overarching goal of the current studies stems from an effort to 
elucidate the mechanisms through which morphine alters stress-enhanced fear learning in order 
to uncover more targets for the development of a prophylactic pharmaceutical to treat PTSD, 
without abuse liability.  
Hippocampal function is important in PTSD and SEFL   
While the experiments described herein focus primarily on the hippocampus, the sole 
focus on this brain region is well-justified. The hippocampus is known as a structure critical to 
memory processing, and data from numerous laboratories confirms that hippocampal function 
is required for contextual fear learning (Phillips and LeDoux 1992; Maren, Anagnostaras et al. 
1998; Anagnostaras, Gale et al. 2001; Izquierdo, Furini et al. 2016). In addition, the 
hippocampus is considered to be an important component of the limbic system, a set of 
interconnected regions known to be critical in emotional processing (Bubb, Kinnavane et al. 
2017). Not surprisingly, data from both human and animal laboratories has implicated the 
hippocampus in PTSD and PTSD-like phenotypes using rodent models of stress (Woodward, 
Kaloupek et al. 2006; Kozlovsky, Zohar et al. 2012; Chao, Yaffe et al. 2014; Jones, Lebonville 
et al. 2015; O'Doherty, Chitty et al. 2015; Rubin, Shvil et al. 2016; Nelson and Tumpap 2017). 
PTSD patients exhibit reduced hippocampal volume compared to traumatized and non-
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traumatized controls (O'Doherty, Chitty et al. 2015) and an interesting recent report suggests 
that the dentate gyrus volume, specifically, is reduced (Hayes, Hayes et al. 2017). Furthermore, 
within PTSD populations, hippocampal volume is inversely related to treatment outcomes such 
that greater hippocampal volume predicts a more favorable treatment response (Rubin, Shvil 
et al. 2016).  
A better understanding of the neurobiological mechanisms driving the acquisition of 
traumatic or stressful memories is an important step in understanding PTSD. The specific aims 
described herein make contributions to a greater effort to better understand the hippocampal 
mechanisms that influence memory acquisition and how such mechanisms might differ 
between traumatic or stressful vs. normal memories and experiences. How the current findings 
relate to potential mechanisms that have been hypothesized to be involved in memory 
acquisition and learning, including alterations in dendritic spine morphology/ synaptic 
remodeling (Yang, Pan et al. 2009; Lai, Franke et al. 2012; Giachero, Calfa et al. 2015) and 
secretion of glial-derived neurotrophic factors in the hippocampus (Bekinschtein, Cammarota 
et al. 2014; Rosas-Vidal, Do-Monte et al. 2014), is discussed throughout Chapters 3 through 
5.   
Role of cytokine signaling in stress response mechanisms  
Psychopathology and disease states involving depression and anxiety have been 
associated with altered immune function in both human studies and preclinical rodent models 
(Gill, Saligan et al. 2009; Guo, Liu et al. 2012; Gola, Engler et al. 2013; Passos, Vasconcelos-
Moreno et al. 2015; Wang and Young 2016).  In parallel, cytokines in the central nervous 
system have recently emerged as important signaling molecules in the brain that modulate a 
wide range of behaviors, including stress response (Goshen and Yirmiya 2009; Bull, Freitas et 
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al. 2014; Hutchinson and Watkins 2014). Recent evidence also suggests that cytokines can 
directly influence learning and memory processes (Goshen, Kreisel et al. 2007; Goshen and 
Yirmiya 2009). The experiments described in the current dissertation are based on the 
conceptually innovative hypothesis that neuroimmunological mechanisms are involved in the 
development and expression of PTSD.  
Interleukin-1β (IL-1β) is a proinflammatory cytokine thought to underlie many of the 
parallels between the body’s response to psychological stress and physical illness. Both 
conditions lead to a phenotype termed sickness behavior, which is characterized in part by 
enhanced anxiety (Dantzer 2009; Goshen and Yirmiya 2009). More recently, IL-1β has been 
shown to be critical to fear learning and memory related phenomena (Goshen, Kreisel et al. 
2007). Interestingly, several groups have also reported upregulated circulating peripheral 
cytokines, including IL-1β, in PTSD patients (Gill, Saligan et al. 2009; Guo, Liu et al. 2012; 
Gola, Engler et al. 2013; Lindqvist, Wolkowitz et al. 2014; Passos, Vasconcelos-Moreno et al. 
2015; Wang and Young 2016), even suggesting cytokine expression as a biomarker for 
affected individuals following trauma (Cohen, Meir et al. 2011).  
Recently, we examined the time course of IL-1β immunoreactivity and mRNA 
expression in the brain over the 72 hours following exposure to the severe stressor within the 
SEFL paradigm. Published data from our laboratory demonstrates that the severe stressor of 
SEFL, that is capable of inducing a PTSD-like phenotype (enhanced fear learning), induces a 
time-dependent increase in IL-1β immunoreactivity and mRNA expression specifically in the 
dorsal hippocampus, with no effect of foot shock on IL-1β expression in the basolateral 
amygdala or the perirhinal cortex (Jones, Lebonville et al. 2015). The effect emerges at 6 hours 
post-stress and persists through 72 hours post-stress. Of note, we also quantified IL-1β 
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immunoreactivity by hippocampal subregion, and the dentage gyrus exhibited the most dense 
IL-1β expression by far (relative to cornu ammonis (CA)1 and CA3). A subsequent experiment 
showed that centrally blocking IL-1 signaling through an intracerebroventricular (ICV) 
infusion of IL-1 receptor antagonist (IL-1RA) at 24 and 48 hours after Context A exposure 
prevented the development of SEFL (Jones, Lebonville et al. 2015). These data strongly 
suggest that IL-1 is causally related to SEFL in the hippocampus. Furthermore, the extremely 
dense IL-1β signal observed in the dentate gyrus is interesting given the recent report that the 
dentate gyrus, specifically, may be altered in human populations diagnosed with PTSD as well 
(Hayes, Hayes et al. 2017). Follow up studies found that the same systemic morphine treatment 
that prevented the development of SEFL (Szczytkowski-Thomson, Lebonville et al. 2013) also 
attenuated hippocampal stress-induced IL-1β (Jones, Lebonville et al. 2015). Collectively, our 
published work provides strong evidence that morphine exerts an anti-inflammatory effect on 
the hippocampus that has direct implications in fear learning behavior.  
Given that the stress-induced increase in IL-1β was specific to the dorsal hippocampus, 
the first goal of the current dissertation was to directly test whether hippocampal IL-1 signaling 
is involved in the development of SEFL. Subsequently, our attention shifted to understanding 
the cellular signaling dynamics of stress-induced IL-1β in this region. IL-1β can be expressed 
by astrocytes, microglia, and neurons and IL-1 activation can lead to distinct signaling 
pathways in each cell type (Srinivasan, Yen et al. 2004). Understanding the complex cellular 
signaling dynamics of stress-induced hippocampal IL-1 is critical to the development of 
pharmacological agents that can attenuate maladaptive inflammatory signaling in the CNS that 
contributes to PTSD without interfering with peripheral immune defense (O'Neill 2006). As 
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an important first step to this endeavor, the second goal of the current dissertation was to 
identify the cellular source of hippocampal stress-induced IL-1β.  
Role of astroglial signaling in stress response mechanisms  
While cytokines can be expressed by multiple cell types in the brain, astrocyte-derived 
cytokines, including IL-1β, have been increasingly implicated in stress response mechanisms 
(Goshen and Yirmiya 2009) (Sugama, Takenouchi et al. 2011). Data presented in Chapter 2 of 
the current dissertation provides even further support for this hypothesis in that that 
hippocampal astrocytes are the cellular source of stress-induced IL-1β, which we have shown 
to be causally related to the development of SEFL (See Figures 1.4 and 1.5). Traditionally 
viewed merely as neuronal “glue”, glial cells are now known to be critically involved in a 
diverse array of functions in development and disease of the central nervous system (CNS), 
however, the heterogeneity of glia remains underappreciated (Barres 2008). We argue that 
astrocyte function, especially in the context of severe stress, merits further scientific study.  
Astrocytes are process-bearing cells that make direct contact with synapses (Blanco-
Suarez, Caldwell et al. 2016). A “tripartite” synapse consists of a pre-synaptic cell, a post-
synaptic cell, and an astrocyte that envelops the synapse. Converging evidence confirms that 
in this context, astrocytes engage in bidirectional communication with neurons through the 
release of gliotransmitters, such as ATP, d-serine, and/or glutamate, such that astrocytes can 
directly regulate synaptic transmission (Bernardinelli, Randall et al. 2014; Blanco-Suarez, 
Caldwell et al. 2016).  
While there are several reports of stress-induced changes in astrocyte reactivity and 
morphology, there are inconsistencies regarding changes in astrocytes throughout the brain in 
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depressive and anxiety-like phenotypes that are observed in PTSD. Glial fibrillary acidic 
protein (GFAP) expression, a cytoskeletal protein selectively expressed by astrocytes and 
commonly employed as a marker of astrocyte activation or reactivity, has been reported to be 
altered in several brain regions, including the hippocampus, following a variety of different 
stress protocols (Colombo and Farina 2016) (Tynan, Beynon et al. 2013; Xia, Zhai et al. 2013; 
Choi, Ahn et al. 2016; Saur, Baptista et al. 2016). Impaired astrocyte glutamate transport, 
decreased release of astrocyte-derived neurotrophic factors, and altered astrocyte density have 
also been observed in the context of preclinical models of depression (Niciu, Henter et al. 
2014). Furthermore, effective antidepressants, which are sometimes used to alleviate PTSD 
symptoms, have been associated with gliotrophic effects (Czeh, Muller-Keuker et al. 2007; 
Banasr, Chowdhury et al. 2010; Niciu, Henter et al. 2014). Given the significant role of the 
hippocampus in PTSD described above, it is important to note a recent report by Iwata and 
colleagues showed that the protective effect of imipramine in a model of learned helplessness 
was blocked by fluorocitrate, a reversible astrocyte inhibitor, directly into the hippocampus 
(Iwata, Shirayama et al. 2011). Similarly, Zhang and colleagues demonstrated that gastrodin, 
a compound shown to protect against depressive-like phenotypes, acts by enhancing astrocyte-
derived brain-derived neurotrophic factor (BDNF) (Zhang, Peng et al. 2014).  
In summary, evidence from multiple rodent paradigms of stress-induced depressive or 
anxiety-like behavior, as is seen in PTSD, suggests that astrocyte function may be important 
in the behavioral consequences of stress. Another overarching goal of the current dissertation 
was to gain a better understanding of hippocampal astrocyte function in the context of SEFL. 
To accomplish this, we took advantage of two novel innovations that have recently become 
available to study astrocytes with impressive precision and specificity. These new technologies 
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allow researchers to thoroughly describe the morphometric properties of astrocytes and to 
directly manipulate astroglial G protein coupled receptor (GPCR) signaling in vivo.  
High resolution analysis of the morphometric properties of astrocytes  
Dr. Kathryn Reissner and colleagues have optimized a method to isolate and quantify 
astrocyte volume and synaptic contacts throughout a 3-dimensional reconstruction of an 
individual cell (Scofield, Li et al. 2016). With their method, an adeno-associated virus serotype 
5 (AAV) is used to express Green Fluorescent Protein (GFP) in a membrane-dependent manner 
under a GFAP promoter such that entire astrocyte, including the most distal perisynaptic 
processes can be visualized and quantified. Double label fluorescence immunohistochemistry 
can be used to quantify the colocalization of GFP with synaptic markers, such as synapsin or 
postsynaptic density 95, within an individual cell. As such, high resolution confocal 
microscopy and Bitplane Imaris analysis can produce thorough measures of the volume, 
surface area, and synaptic colocalization of individual astrocytes. This technology has been 
employed in one peer-reviewed article thus far and is known to produce results that are robust 
and reliable (Scofield, Li et al. 2016). The goal of Chapter 3 of the current dissertation was to 
employ this technology to analyze how the severe stressor the SEFL paradigm alters the 
morphometric properties of hippocampal astrocytes.  
Glial-expressing Designer Receptors Exclusively Activated by Designer Drugs 
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are 
synthetically engineered muscarinic receptors that have lost their affinity for acetylcholine but 
can be activated by Clozapine-n-oxide (CNO), which crosses the blood brain barrier when 
injected peripherally (Zhu and Roth 2014; Roth 2016). AAVs can be used to express 
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DREADDs coupled to Gi, Gq, or Gs under a variety of different promotors in a brain region-
specific manner. While it is important to note that CNO may have non-specific physiological 
effects that need to be controlled for (Roth 2016), this technology allows researchers to non-
invasively manipulate GPCR signaling in the brain in a cell-specific and region-specific 
manner. Glial-expressing DREADD constructs have now been developed such that astrocyte 
GPCR signaling can also be manipulated. The studies described herein take advantage of this 
technology to examine the role of astroglial GPCR signaling in the context of SEFL. The goal 
of Chapter 4 of the current dissertation was to test whether activation of hippocampal astroglial 
Gi signaling is sufficient to attenuate SEFL.  
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Specific Aims  
As reviewed above, PTSD is a debilitating condition that imposes severe fiscal and 
emotional costs on society. A better understanding of the neurobiological mechanisms driving 
PTSD is crucial to the development of more targeted treatments. Rodent paradigms that 
examine behavioral responses to severe stress can be used to elucidate mechanisms involved 
in PTSD-like behaviors. The goal of the current dissertation was to examine hippocampal 
neural immune signaling as a potentially important mechanism involved in stress-enhanced 
fear learning, a PTSD-like phenotype. To accomplish goal, the three specific aims described 
below examined stress-induced changes at the cellular level in the hippocampus following 
severe stress and tested the involvement of two specific signaling pathways in the development 
of SEFL.  
Cytokines in the central nervous system have recently emerged as important signaling 
molecules in the brain that modulate a range of behaviors, including stress response (Goshen 
and Yirmiya 2009; Bull, Freitas et al. 2014; Hutchinson and Watkins 2014). We have 
previously published strong preliminary data to suggest that hippocampal interleukin-1 
signaling may be critical to the development of SEFL (Jones, Lebonville et al. 2015). Further, 
while the cellular source of stress-induced IL-1β remains unclear, astrocyte signaling, 
including astrocyte-derived cytokine signaling, has also been hypothesized to be important in 
behavioral responses to stress in rodent models of PTSD (Ben Menachem-Zidon, Avital et al. 
2011; Xia, Zhai et al. 2013; Levkovitz, Fenchel et al. 2015). The experiments described below 
and in Chapters 2 through 4 tested the overarching hypothesis that (1) severe stress induces 
changes in hippocampal astrocyte-derived IL-1β expression and the morphometric properties 
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of astrocytes and (2) that both blocking hippocampal IL-1 signaling and activating 
hippocampal astroglial Gi signaling prevent the development of SEFL (Figure 1.3).  
Specific Aim 1 tested the hypothesis that blocking IL-1 signaling in the dorsal 
hippocampus prevents SEFL and isolated the specific cellular source of hippocampal 
stress-induced IL-1β.  Strong preliminary data suggest that blocking IL-1 signaling directly 
in the dorsal hippocampus is sufficient to prevent the development of SEFL. However, the 
cellular source of hippocampal stress-induced IL-1 remains unknown. The experiments in this 
aim contribute to our understanding of the role of central IL-1 in SEFL in that we (1) directly 
tested whether dorsal hippocampal IL-RA is sufficient to attenuate SEFL and (2) identified the 
cellular source of stress-induced IL-1. Furthermore, analyses in this aim contribute to our 
knowledge of stress-induced changes of two common markers for astrocytes and microglia, 
glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor molecule -1 (Iba-
1). Specific Aim 1 is described in Chapter 2.  
Specific Aim 2 tested the hypothesis that astrocyte volume and synaptic contacts 
are altered and postsynaptic density 95 immunoreactivity is decreased following severe 
stress. Preliminary data suggest that astrocytes are one cellular source of stress-induced IL-1β 
(Sugama, Fujita et al. 2007) and astrocyte-dependent signaling has shown promise to prevent 
PTSD (Ben Menachem-Zidon, Avital et al. 2011; Xia, Zhai et al. 2013). This aim advances 
our understanding of how the morphology of astrocytes may be affected by severe stress 
exposure. We used novel technology to isolate and quantify astrocyte surface area, volume, 
and synaptic contact through 3-Dimensional reconstructions of individual hippocampal 
astrocytes (Scofield, Li et al. 2016). In analyzing hippocampal astrocyte synaptic contacts, we 
also tested the hypothesis that stress attenuates PSD95 immunoreactivity. Implications of a 
17 
 
potential stress-induced reduction in postsynaptic density 95 (PSD95) are discussed. Specific 
Aim 2 is described in Chapter 3.  
Specific Aim 3 tested the hypothesis that astroglial Gi activation attenuates SEFL 
expression. Data from Chapter 2 provides strong evidence that astrocyte-derived IL-1β can 
influence SEFL and GPCR signaling has been shown to regulate IL-1β expression (Ye 2001). 
This aim makes a significant contribution to our understanding of glial-expressing DREADDs 
and our understanding of the role of astrocyte signaling in SEFL. In this aim, we tested the 
hypothesis that hippocampal astroglial Gi signaling is sufficient prevent SEFL. In addition, we 
measured colocalization of the GFAP-hM4Di-positive cells with cAMP, a Gi-dependent 
second messenger, in an effort to validate the function of this DREADD. Specific Aim 3 is 
described in Chapter 4.   
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Figure 1.3 Experiments described in Chapters 2 through 4 address three Specific Aims. 
The goal of specific Aim 1 was to test whether dorsal hippocampal IL-1 signaling is required 
for SEFL and to identify the cellular source of stress-induced IL-1β. The goal of Specific Aim 
2 was to provide a thorough analysis of the stress-induced changes in the morphometric 
properties of astrocytes 48 hours after the severe stressor of the SEFL paradigm. (A 
supplemental goal of Specific Aim 2 was to test whether stress attenuates hippocampal PSD95. 
This was done in the process of measuring astrocyte synaptic contacts.) The goal of Specific 
Aim 3 was to test whether hippocampal astroglial Gi signaling is sufficient to attenuate SEFL.  
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Chapter 2 
EXAMINATION OF STRESS-INDUCED HIPPOCAMPAL IL-1β: EFFECT OF 
HIPPOCAMPAL IL-1RA ON STRESS-ENHANCED FEAR LEARNING AND 
IDENTIFICATION OF THE CELLULAR SOURCE2 
Introduction  
Converging evidence from both human and animal studies has suggested that 
psychiatric disorders involving depression and anxiety, including post-traumatic stress 
disorder (PTSD), involve substantial immune system dysregulation (Silverman, Macdougall 
et al. 2007; Gill, Saligan et al. 2009; Koo and Duman 2009; Stepanichev, Dygalo et al. 2014; 
Jones, Lebonville et al. 2015). As mentioned previously, several published studies have 
reported that PTSD is associated with elevated peripheral cytokines, including interleukin-1β 
(IL-β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) (Gill, Saligan et al. 2009; 
Guo, Liu et al. 2012; Gola, Engler et al. 2013; Passos, Vasconcelos-Moreno et al. 2015; Wang 
and Young 2016). Cohen and colleagues have even suggested IL-1 as a potential biomarker 
for susceptibility to PTSD (Cohen, Meir et al. 2011). Central IL-1 signaling is consistently 
shown to be upregulated by a variety of different stress protocols in rodents and to be critically 
involved in stress response mechanisms that drive behavioral outcomes (Avital, Goshen et al. 
2003; Goshen and Yirmiya 2009). For example, peripheral administration of IL-1β has been 
shown to lead to enhanced anxiety-like behavior in the elevated plus maze (EPM) (Swiergiel 
                                                          
2 This chapter is published as an article in Brain, Behavior, and Immunity. Jones, M. E., C. L. 
Lebonville, et al. (2017). "Hippocampal interleukin-1 mediates stress-enhanced fear learning: 
A potential role for astrocyte-derived interleukin-1beta." Brain Behav Immun. 
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and Dunn 2007), and blocking IL-1 signaling centrally prevents stress-induced reductions in 
social interaction (Arakawa, Blandino et al. 2009). As mentioned in Chapter 1, we recently 
published the finding that stress-enhanced fear learning (SEFL), a preclinical animal model of 
PTSD developed by Rau and colleagues (Rau, DeCola et al. 2005), requires central IL-1 
signaling. Our data demonstrated that the severe stressor of the SEFL paradigm (15 foot 
shocks) induces an increase in IL-1β in the dorsal hippocampus (DH) 24-48 hours after the 
stressor. Furthermore, blocking IL-1 signaling in the brain through an intracerebroventricular 
infusion of IL-1 receptor antagonist (IL-1RA) prevents the development of enhanced fear 
learning (Jones, Lebonville et al. 2015). Together these data suggest that central IL-1RA may 
be acting specifically in the hippocampus. Accordingly, the first goal of the current chapter 
was to test whether hippocampal IL-1 signaling 24-48 hours after severe stress is necessary for 
the expression of SEFL.  
The second goal of the current chapter was to isolate and quantify colocalization of 
stress-induced IL-1β with cell-specific markers glial fibrillary acidic protein (GFAP), 
ionized-calcium binding adaptor molecule-1 (Iba-1), and neuronal nuclear antigen (NeuN) 
in order to isolate the cellular source of stress-induced hippocampal IL-1β. IL-1β can be 
expressed by many cell types in the brain, including microglia, astrocytes, and neurons 
(Yabuuchi, Minami et al. 1994; Guasch, Blanco et al. 2007; Ringwood and Li 2008; Flannery 
and Bowie 2010; Zhang, Sun et al. 2010; Huang, Smith et al. 2011). A critical component to 
better understanding the mechanism through which hippocampal IL-1 might influence 
behavioral outcomes following stress is to identify which cell type(s) produce(s) it in response 
to stress. While there is evidence of IL-1 expression in neurons (Kwon, Seo et al. 2008; Zhang, 
Sun et al. 2010; Huang, Smith et al. 2011), there is only one report to our knowledge of an 
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effect of stress on neuron-derived IL-1β. Kwon and colleagues reported an increase in IL-1β 
colocalized with neuronal nuclei following four days of restraint stress (Kwon, Seo et al. 2008). 
In contrast, there are several published studies to support the potential for microglia-derived or 
astrocyte-derived IL-1β, as described below.  
Microglia are brain macrophage cells that play important roles in the healthy brain, 
both maintaining the cellular environment and protecting against injury or immune challenge 
(Perry, Hume et al. 1985; Minghetti, Ajmone-Cat et al. 2005; Block, Zecca et al. 2007; Calcia, 
Bonsall et al. 2016; Mendiola and Cardona 2017). A substantial population of microglia are 
present in the hippocampus (Lawson, Perry et al. 1990), and IL-1β is just one of the 
proinflammatory mediators released by activated microglia (Perry, Hume et al. 1985; 
Minghetti, Ajmone-Cat et al. 2005; Block, Zecca et al. 2007; Mendiola and Cardona 2017). 
While microglial activation and release of proinflammatory cytokines are well-established in 
the context of neurodegenerative diseases, there are inconsistencies regarding the timing, brain 
region–specificity, and direction of the effect of psychological stressors on microglia. Two 
independent groups reported no change in microglial gene expression in the hippocampus 
immediately following exposure to foot shock (Blandino, Barnum et al. 2009; Brzozowska, 
Smith et al. 2017). However, Sugama and colleagues reported that microglial activation was 
increased one to six hours following a two hour exposure to restraint stress in the thalamus, 
hypothalamus, and hippocampus (Sugama, Fujita et al. 2007). Interestingly, in the same report, 
hypothalamic microglial activation was only associated with an increase in IL-1β mRNA and 
immunoreactivity when induced by lipopolysaccharide (LPS), but not when induced by 
restraint stress. Consistent with an increase in microglial activation and proliferation in 
response to stress, Frank et al. reported that major histocompatibility complex II 
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immunoreactivity (MHC II, predominantly expressed by microglia) was increased in the 
hippocampus 24 hours after inescapable tail shock (Frank, Baratta et al. 2007), but they 
observed no change in either GFAP or Iba-1 immunoreactivity in the same tissue.  
The final candidate for a potential source of stress-induced IL-1β is astrocytes. As 
mentioned in Chapter 1, though traditionally viewed merely as neuronal “glue”, astrocytes are 
now known to be critically involved in a diverse array of functions in development and disease 
(Barres 2008). Converging evidence from several laboratories using a variety of different 
severe stress procedures suggests that both GFAP expression and astrocyte process length are 
altered over time in the brain following stress (Tynan, Beynon et al. 2013; Xia, Zhai et al. 
2013; Choi, Ahn et al. 2016; Saur, Baptista et al. 2016). Choi and colleagues observed an 
increase in the length and number of astrocyte processes but a decrease in GFAP in the DH 
one hour, but not 24 hours, after exposure to foot shock fear conditioning (Choi, Ahn et al. 
2016). In contrast, others have observed decreases in the number of astrocyte processes either 
following chronic restraint stress (Tynan, Beynon et al. 2013) or 24-48 hours after foot shock 
exposure (Saur, Baptista et al. 2016). Of particular relevance here, Sugama and colleagues 
found that IL-1β expression was increased specifically in astrocytes, and not microglia, 
following cold stress (Sugama, Takenouchi et al. 2011).  
Importantly, much of the previous literature regarding gene expression and 
morphology of both astrocytes and microglia focuses on early time points post-stress. Given 
that we have previously reported that the IL-1-dependent mechanism that attenuates the 
development at SEFL is specific to the later time points following stress, 24-48 hours 
(Szczytkowski-Thomson, Lebonville et al. 2013; Jones, Lebonville et al. 2015), here we focus 
on changes in the DH at 48 hours after foot shock stress. Specifically, Experiment 2.1 tested 
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whether IL-1 signaling in the DH is critical to the development of a PTSD-like phenotype in 
SEFL. Experiment 2.2 examined stress-induced changes in astrocytes and microglia in the DH 
and identified the cellular source of stress-induced IL-1β in this region. Analyses from 
Experiment 2.2a replicated our previous finding of stress-induced IL-1β in the dorsal 
hippocampus. Analyses from Experiment 2.2b quantified GFAP and Iba-1 immunoreactivity 
to examine stress-induced changes in astrocytes and microglia, respectively. Finally, analyses 
in Experiment 2.2c used Bitplane Imaris software in combination with confocal microscopy to 
visualize the colocalization of IL-1β with GFAP, Iba-1, and NeuN following foot shock to 
isolate and quantify astrocyte-derived, microglia-derived, and neuron-derived IL-1β, 
respectively. Collectively, these experiments tested the hypotheses that IL-1 signaling in the 
DH is critical for the development of SEFL and that astrocytes are the predominant cellular 
source of hippocampal IL-1β following stress in this context.  
Methods 
Animals  
Male Sprague Dawley rats (225-250 g, Charles River Laboratories, Raleigh, NC) were 
housed individually under a reversed 12 hour light-dark cycle. They were given ad libitum 
access to food and water and were handled regularly throughout all experiments. All 
procedures were conducted in accordance with and approval by the UNC Institutional Animal 
Care and Use Committee.  
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Experiment 2.1: Effect of intra-dorsal hippocampal IL-1RA on the development of SEFL 
Surgery  
Animals were anesthetized with a 1.0 mg/kg intraperitoneal injection of 9:1 (vol:vol) 
ketamine hydrochloride (100mg/ml) mixed with xylazine (100 mg/ml). Guide cannulae (26 
Gauge, Plastics One, Roanoke, VA) were directed bilaterally at the DH (AP -3.4 mm, ML ± 
3.1 mm, DV -2.2 mm, 15 degrees, relative to bregma). Animals were given one week for 
postoperative recovery prior to the start of any experimental procedures. Upon completion of 
the experiment, correct cannula placement was verified and any animals with incorrect 
placement were dropped from the analysis.  
Stress-enhanced fear learning  
All animals (N = 36, n = 9) were assigned to a Context A treatment (Foot Shock in 
Context A or No Foot Shock in Context A) and a drug treatment (IL-1RA or vehicle) and 
exposed to the SEFL paradigm (Figure 2.1), as has been previously described (Szczytkowski-
Thomson, Lebonville et al. 2013; Jones, Lebonville et al. 2015). Briefly, on Day 1, animals 
were exposed to Context A (BRS/LVE, Laurel, MD; 26.7 cm × 24.8 cm × 30.7 cm) which was 
housed in a separate room with distinct textile, olfactory, and auditory characteristics from the 
home cage. Animals assigned to the Foot Shock in Context A condition received 15 2 mA 
scrambled foot shocks over 90 minutes on a 6 minute variable interval schedule while control 
animals were exposed to the context for the same amount of time without foot shocks being 
delivered. Six days later, animals were exposed to Context B, a standard rodent chamber 
housed in a wooden sound attenuating cubicle (Med Associates, St. Albans, VT, 20.5 cm x 
23.5 cm x 30.7 cm), which was again housed in a separate room from Context A and the home 
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cage. Context B was also associated with distinct textile, olfactory, and auditory characteristics 
from both Context A and the home cage. In addition, behavior in Context B was recorded using 
a video recording system (Sony Video Camera Model HDR-CX150). Similar to Rau and 
colleagues (Rau, DeCola et al. 2005), animals were exposed to Context B for 30 minutes 
without foot shocks being delivered to allow for habituation to the new context. On Day 8, 
animals were placed back into Context B where all animals received a single 1 mA scrambled 
foot shock, 3 minutes, 12 seconds after being placed into the context. Behavior during the three 
minutes prior to the single shock was recorded and analyzed to test for generalization of fear 
between the two contexts (these data are presented as ‘baseline’). On Days 9, 10, 15 and 22 
(Test Days 1, 2, 7 and 14), animals were placed in Context B for 8 minutes, 32 seconds and 
behavior was recorded.   
Ethovision XT video tracking software (Noldus Information Technology Inc.) was 
used to analyze freezing behavior, a measure of learned fear defined as a lack of all movement 
except that required for breathing. Specifically, the activity analysis feature (Activity 
Threshold = 10) was used to calculate the percent of time each animal was inactive during each 
contextual fear test and at baseline. No animals in any group demonstrated significant freezing 
behavior to Context B prior to the single foot shock, suggesting that there was no generalization 
of fear between contexts (Results 2.1). Thus, any differences observed between treatment 
groups presented here reflect altered learning to the single foot shock in Context B.  
IL-1 receptor antagonist  
IL-1RA (GenScript, Piscataway, NJ) was reconstituted in sterile saline (2.5 µg/µl). 
Twenty-four hours prior to Context A exposure, animals were given a sham microinfusion to 
allow for habituation to microinfusion procedures. Twenty-four and 48 hours after removal 
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from Context A, on Days 2 and 3, animals were microinfused with 1.25 µg of IL-1RA or sterile 
saline vehicle per hemisphere at a rate of 0.25 µl/min. Injectors had a 1mm projection and were 
left in place for 1 minute after the infusion to allow for diffusion. These time points were based 
on our earlier published findings that morphine administration and intracerebroventricular IL-
1RA prevent the development of SEFL when administered 48 hours after Context A 
(Szczytkowski-Thomson, Lebonville et al. 2013; Jones, Lebonville et al. 2015).  
Experiment 2.2: Immunofluorescence analysis of severe stress-induced changes in 
hippocampal GFAP, Iba-1, NeuN, and IL-1β 
Stress exposure 
Animals (N = 16, n = 8) were randomly assigned to either a Foot Shock (in Context A) 
or No Foot Shock (in Context A) treatment and exposed to only the initial severe stressor of 
the SEFL paradigm described in Experiment 2.1. As such, animals assigned to receive foot 
shocks were exposed to 15 2 mA scrambled foot shocks in Context A as described above, an 
environment distinct from the home cage, while control animals were exposed to the same 
context without foot shocks being delivered. Forty-eight hours after removal from Context A, 
animals were deeply anesthetized with 9:1 (vol:vol) ketamine hydrochloride (100 mg/ml) 
mixed with xylazine (100 mg/ml) and transcardially perfused with cold phosphate buffer (PB; 
pH = 7.4) for three minutes at a rate of 15 mls/minute followed by 4% paraformaldehyde in 
0.1M PB for seven minutes at a rate of 15 mls/minute. Brains were extracted, post-fixed in 
paraformaldehyde for 4-6 hours and placed in 30% sucrose with 0.1% sodium azide at 4°C for 
cryoprotection. Brains were sectioned into 40 µm sections on a freezing microtome.  
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Immunohistochemistry 
For colocalization analyses, tissue was stained with three primary antibodies. All 
primary antibodies were verified by no primary control stains in which tissue was only exposed 
to secondary antibodies to ensure specificity of each signal in the triple label. Tissue was first 
washed three times for 10 minutes in 0.1M phosphate buffer (PB, pH = 7.4). For tissue stained 
with anti-Iba-1 antibody, tissue was incubated in endogenous biotin and streptavidin blocks 
(Vector Laboratories, Burlingame, CA, USA) for 30 minutes each at room temperature, 
according to the manufacturer’s instructions. All tissue was incubated in 5% Normal Goat 
Serum (NGS) and 0.5% TritonX100 in 0.1 M PB for 3 hours at room temperature. Tissue was 
incubated in primary antibody, 5% NGS, and 0.5% TritonX100 in 0.1M PB overnight at 4°C, 
washed three times for 10 minutes in 0.1M PB, and incubated in secondary antibody, 5% NGS, 
and 0.5% TritonX100 in 0.1M PB for 60-120 minutes at room temperature. Each antibody was 
applied individually and thus the entire triple stain procedure occurred over three subsequent 
nights. The following primary antibodies were used: rabbit anti-IL-1β (1:500, Abcam, 
Cambridge, MA, Cat # Ab9722), mouse anti-GFAP (1:1000, ThermoFisher Scientific, 
Waltham, MA, Cat # MS-1376P), mouse anti-NeuN-Alexa 568 (1:1000, Abcam Cambridge, 
MA, Cat # Ab207282), and rabbit anti-Iba-1-biotinylated (1:500, Wako, Richmond, VA, Cat 
# 016-26461). To visualize IL-1β and GFAP, goat anti-rabbit Alexa Fluor 488 (1:1000, 
ThermoFisher Scientific, Waltham, MA, Cat #A11008) and goat anti-mouse Dylight 405 
(1:1000, ThermoFisher Scientific, Waltham, MA, Cat # 35501BID) were used. Goat anti-
rabbit Alexa Fluor 488 was applied for 60 minutes and goat anti-mouse Dylight 405 was 
applied for 120 minutes. To visualize Iba1, a streptavidin-conjugated Alexa Fluor 568 antibody 
(1:1000, ThermoFisher Scientific, Waltham, MA, Cat #S11226) was used and was applied for 
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60 minutes. Sections were mounted onto SuperFrost Plus slides (Fisher Scientific, Pittsburgh, 
PA) using Vectashield hard set mounting medium (Vector Laboratories, Burlingame, CA). 
Tissue from poor perfusions that yielded high nonspecific background which interfered with 
thresholding and colocalization calculations was dropped from the analysis, and any such 
decision was made blind to treatment group.  
Confocal microscopy, Bitplane Imaris colocalization analysis, and cell counting   
All image acquisition and analysis was completed by an experimenter blind to 
treatment group. Tissue was imaged using a Zeiss LSM800 confocal microscope with laser 
lines that excite at 405 nm, 488 nm, and 561 nm. Images were acquired using a 63X oil 
immersion lens. Z stacks of the dentate gyrus of the dorsal hippocampus (AP -3.12 mm through 
-3.84 mm from bregma) were acquired using a frame average of 4, 1024 by 1024 frame size, 
12 bit image resolution, and 0.8 µm step size. We focused our analysis on the dentate gyrus 
based on our previous finding that IL-1β expression is most dense in this subregion of the DH 
(Jones, Lebonville et al. 2015).  
Z stacks were deconvolved using Bitplane AutoQuant X3 (10 iterations, (Lee, Wee et 
al. 2014)) and exported to Bitplane Imaris software (Zurich, Switzerland). For background 
correction of each channel individually, absolute intensity thresholds were manually set. In the 
colocalization module, voxels above the threshold in both channels were included as 
colocalized voxels. A two-dimensional scatter plot was used to visually inspect the accuracy 
of colocalization thresholds. The colocalization between IL-1β and GFAP, IL-1β and Iba-1, 
and IL-1β and NeuN was calculated. The following values were recorded: % volume above 
the absolute intensity threshold selected for each channel, % IL-1β colocalized with Iba1, 
GFAP, and NeuN, respectively, and the Pearson’s correlation coefficient for each pair of 
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signals.  In addition to Imaris volume and colocalization analyses, the number of GFAP-
positive and Iba-1-positive cells in the dentate gyrus was counted in images acquired at 10X 
by an experimenter blind to treatment group. 
Statistical analyses  
For Experiment 2.1, a one way ANOVA with treatment group as the between subjects 
factor was used to analyze baseline freezing data during the three minutes prior to the foot 
shock during Context B conditioning in order to ensure there were no group differences in 
freezing to Context B prior to the single shock. A 2 x 2 x 4 repeated measures ANOVA with 
Context A treatment and drug treatment as between subject factors and test day as a within 
subjects factor was used to analyze freezing behavior across test days 1, 2, 7 and 14. For 
Experiment 2.2, unpaired, two-tailed student’s t tests were used to test whether Foot Shock 
treatment altered GFAP or Iba-1 immunoreactivity and an unpaired one-tailed student’s t test 
was used to test whether Foot Shock treatment altered IL-1β immunoreactivity. For 
colocalization data, the percent of IL-1β colocalized with each signal and the Pearson’s 
correlation coefficient for each pair of signals were subjected to a 2 x 3 ANOVA with Foot 
Shock treatment and cell type specific signal analyzed as factors. Significant interactions were 
examined using Tukey’s post-hoc comparisons. Specifically, for Experiment 2.1 planned 
comparisons included: Foot shock in Context A/ Vehicle vs. Foot shock in Context A/ IL-1RA 
and No Foot shock in Context A/ Vehicle vs. Foot shock in Context A/ Vehicle. For 
colocalization data, planned comparisons included GFAP/IL-1β colocalization parameters vs. 
Iba-1/IL-1β colocalization parameters and GFAP/IL-1β colocalization parameters vs. 
NeuN/IL-1β colocalization parameters.    
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Results  
Experiment 2.1: Intra-dorsal hippocampal IL-RA prevents SEFL 
Figure 2.1 shows freezing behavior across all four test days. There was no effect of 
Context A treatment on baseline freezing in Context B prior to the single shock, F (3, 24) = 
2.674, p > 0.05, confirming that there was no generalization of fear between the two contexts. 
A 2 x 2 x 4 ANOVA revealed a significant main effect of Context A treatment, F (1, 23) = 
5.159, p = 0.033, and a significant main effect of drug treatment, F (1, 23) = 9.354, p = 0.006. 
In addition, there was a significant main effect of test day, F (1, 23) = 23.344, p < 0.001, 
indicating that contextual fear diminished across test days. Importantly, there was a significant 
Context A treatment by drug treatment interaction, F (1, 23) = 4.394, p = 0.047. Tukey’s post 
hoc comparisons revealed a significant stress-enhanced fear learning effect within vehicle-
treated groups in that foot shock in Context A significantly enhanced freezing to Context B, p 
= 0.038. Critically, IL-1RA treatment prevented stress-enhanced fear learning within groups 
that received foot shock in Context A. Rats that received foot shock in Context A followed by 
IL-1RA exhibited significantly less freezing than rats that received foot shock in Context A 
followed by vehicle, p = 0.001. Further, rats that received foot shock in Context A followed 
by IL-1RA exhibited a comparable amount of freezing behavior (no statistically significant 
difference), to both control groups of rats that received no foot shock in Context A, p > 0.05.  
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Figure 2.1 Intra-dorsal hippocampal IL-1RA is sufficient to prevent SEFL. (A) Schematic 
shows Experiment 2.1 timeline of surgical procedures, intra-DH microinfusions, and severe 
stress exposure and contextual fear learning in the SEFL paradigm.  (B) Paxinos and Watson 
(2007) schematics of the rat brain show approximate cannulae placement. Coordinates -3.0 
through -3.6 from Bregma are shown. Each circle represents where damage from the cannula 
tract was observed for all animals included in the analysis.  (C) DH-IL-1RA significantly 
attenuated SEFL. There were no differences between groups in freezing to Context B prior to 
the single shock. Stress-enhanced fear learning was observed within vehicle-treated groups in 
that rats that received foot shock in Context A followed by vehicle exhibited significantly more 
fear learning to Context B than rats that received no foot shock in Context A followed by 
vehicle. Critically, animals that received foot shock in Context A followed by IL-1RA 
exhibited significantly less freezing than animals that received foot shock in Context A 
followed by vehicle. Thus, IL-1RA prevented the expression of SEFL. * Foot Shock in Context 
A/ Vehicle vs. Foot Shock in Context A/ IL-1RA, p < 0.05. 
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Experiment 2.2a: Stress-induced increase in hippocampal IL-1β is replicated 
We previously reported that the severe stressor of the SEFL paradigm induces an 
increase in hippocampal IL-1β immunoreactivity and mRNA that emerges at 6 hours and 
persists through 72 hours following stress exposure (Jones, Lebonville et al. 2015). Here, this 
effect is replicated in that exposure to the severe stressor of SEFL significantly enhanced 
hippocampal IL-1β immunoreactivity 48 hours later, t (10) = 2.083, p = 0.0319 (Figure 2.2).  
 
 
 
Figure 2.2 Severe stress increases hippocampal IL-1β immunoreactivity. The stress-
induced increase in hippocampal IL-1β that we previously reported is replicated here. 
Representative images of IL-1β immunoreactivity in the dentate gyrus of the DH acquired at 
10X are shown from stressed (Foot Shock in context A) and non-stressed (No Foot Shock in 
Context A) rats. Top panel shows a tiled 10X image, while bottom panel shows a single 10X 
image. For the bottom panel, Bitplane Imaris was used for background subtraction to better 
visualize individual cells presented. Paxinos and Watson (2007) schematic shows the 
approximate region of the DH where images were acquired, AP -3.36 from bregma. 
Quantification of IL-1β immunoreactivity revealed that exposure to severe stress (15 foot 
shocks) significantly increased IL-1β immunoreactivity in the DH 48 hours post-stress. * p < 
0.05.  
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Experiment 2.2b: Severe stress attenuates Iba-1, but not GFAP, in the dorsal hippocampus 
Exposure to severe stress did not alter hippocampal GFAP immunoreactivity. There 
was no effect of Context A treatment on Imaris quantification, t (9) = 1.295, p > 0.05, or the 
number of GFAP-positive cells, t (11) = 0.9563, p > 0.05. However, exposure to severe stress 
significantly reduced hippocampal Iba-1 immunoreactivity. Exposure to Foot Shock in 
Context A attenuated both Imaris quantification of Iba-1 immunoreactivity, t (9) = 2.497, p = 
0.0340, and the number of Iba-1-positive cells, t (10) = 2.375, p = 0.0389. Figure 2.3 shows 
representative images and quantification of hippocampal GFAP and Iba-1, respectively.  
 
 
 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Dorsal hippocampal Iba-1 immunoreactivity, but not GFAP 
immunoreactivity, is attenuated 48 hours after severe stress. (A). Representative images of 
GFAP and Iba-1 immunoreactivity acquired at 10X (tiled image presented) and 20X are shown 
from stressed (Foot Shock in Context A) and non-stressed (No Foot Shock in Context A) rats. 
Images were acquired in the DH, AP -3.36 from bregma. (B) Both Imaris quantification and 
individual GFAP-positive cell counts indicated there was no effect of stress on GFAP 
immunoreactivity. (C) In contrast, Imaris quantification and individual Iba-1 positive cell 
counts revealed that stress exposure significantly attenuated Iba-1 immunoreactivity 48 hours 
post-stress. * p < 0.05. 
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Experiment 2.2c: Stress-induced hippocampal IL-1β is colocalized primarily with GFAP in 
both stressed and non-stressed animals 
Figures 2.4 and 2.5 show that there was an overwhelming amount of IL-1β colocalized 
with GFAP, 75% to 79% of the IL-1β signal, and only minimal colocalization with Iba-1 or 
NeuN, less than 5% of the IL-1β signal. Thus, there was over 15- fold greater colocalization 
of IL-1β with GFAP compared to the other two cell-type markers in both stressed and non-
stressed animals. As such, there was a significant main effect of cell-type analyzed in both the 
% IL-1β signal colocalized, F (2, 28) = 2423.859, p < 0.001, and the Pearson’s correlation 
coefficient, F (2, 28) = 51.166, p < 0.001. Again, regarding both the % IL-1β signal colocalized 
and the Pearson’s correlation coefficient, post hoc comparisons confirmed significantly more 
colocalization with GFAP than Iba-1, p < 0.001, and with GFAP than NeuN, p < 0.001. There 
was no difference between colocalization of IL-1β with Iba-1 and with NeuN, p > 0.05.  
The cellular distribution of IL-1β was not changed by exposure to severe stress (Figure 
2.4). There was no main effect of Context A treatment on either the % IL-1β colocalized with 
each signal, F (1, 28) = 1.949, p > 0.05, or the Pearson’s correlation coefficient between signals, 
F (1, 28) = 1.749, p  > 0.05.  
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Figure 2.4 IL-1β signal is colocalized with GFAP, and not with Iba-1 or NeuN, in the 
dorsal hippocampus in stressed and non-stressed animals. (A) Representative images of 
IL-1β, NeuN, Iba-1, and GFAP immunoreactivity in the dentate gyrus of the DH (AP -3.36 
mm from bregma) acquired at 20X are shown. Because we did not detect any differences in 
colocalization between stressed and non-stressed rats, all images here are taken from animals 
that received stress exposure. Bitplane Imaris was used for background subtraction to better 
visualize individual cells presented. (B) Bitplane Imaris software was used to calculate the 
colocalization of the IL-1β signal with GFAP, Iba-1, and NeuN. Colocalization analyses 
revealed that the percent of the IL-1β signal colocalized with GFAP was significantly greater 
than the percent of the IL-1β signal colocalized with either Iba-1 or NeuN. * p < 0.05. (C) 
Similarly, the Pearson’s correlation coefficient between the IL-1β signal intensity and the 
GFAP signal intensity was significantly higher than that for the IL-1β signal and Iba-1 signal 
or NeuN signal, respectively. * p < 0.05. 
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Figure 2.5. IL-1β signal is colocalized with GFAP, and not with Iba-1 or NeuN, in the 
dorsal hippocampus in stressed and non-stressed animals. Representative images from the 
DH acquired at 63X (scale bar presented is 10 µm) show colocalization of IL-1β with GFAP, 
Iba-1, and NeuN. Because we did not detect any differences in colocalization between stressed 
and non-stressed rats, all images here are taken from animals that received stress exposure. 
Colocalization panels (white, labeled ‘Coloc’) show Imaris-generated image of colocalized 
voxels in each Z stack image presented. Colocalization scatter plots show the signal intensity 
for each voxel in the Z stack. Specifically, color of each point represents the frequency, the Y 
axis represents IL-1β signal (Alexa Fluor-488) intensity, and the X axis represents GFAP 
(Dylight 405), Iba-1 (Alexa Fluor 568), or NeuN signal (Alexa Fluor 568) intensity, 
respectively. In the top panel, the colocalization scatter plot between IL-1β and GFAP shows 
a high proportion of voxels that were high in both IL-1β and GFAP signal (selected region), 
and a high observed correlation, r = 0.3997, demonstrates that for any given voxel, as IL-1 
signal increased, GFAP signal was also likely to increase. In contrast, scatter plots for both IL-
1β with Iba-1 and IL-1β with NeuN show a high proportion of voxels that were high in only 
IL-1β or Iba-1 and NeuN signal, respectively (outside of selected region). In addition, there 
was a lower correlation for the IL-1β and Iba-1 signal, r = 0.1915, and IL-1β and NeuN signal, 
r = 0.0373, suggesting a much weaker relationship than that with GFAP.  
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Discussion  
In the current chapter, we provide evidence that astrocytes are the cellular source of 
foot shock-induced hippocampal IL-1β, which plays a critical role in the development of SEFL, 
an animal model of PTSD. Experiment 2.1 supports our hypothesis that dorsal hippocampal 
IL-1 signaling is necessary for the development of SEFL in that intra-DH IL-1RA infused 24 
and 48 hours following severe stress prevented the expression of SEFL. Further, Experiment 
2.2 provides the first evidence that Iba-1 immunoreactivity is reduced 48 hours following foot 
shock stress and that the IL-1β signal at this critical time point for behavioral consequences of 
severe stress is almost exclusively colocalized with an astrocyte-specific marker, and not with 
microglia- or neuron-specific markers.  
Our finding that hippocampal astrocytes are the predominant source of stress-induced 
hippocampal IL-1β is consistent with previously published data suggesting that astrocyte-
dependent signaling is important in stress and anxiety-related behavior (Barres 2008; Ben 
Menachem-Zidon, Avital et al. 2011; Cao, Li et al. 2013; Xia, Zhai et al. 2013; Rial, Lemos et 
al. 2015). These findings will be discussed further in Chapter 4. However, one limitation of 
the current findings is that future studies are needed to provide insight into the potential causal 
link between astrocyte signaling and SEFL. For example, to test whether astrocyte-derived IL-
1, specifically, is causally related to SEFL, future studies could examine the development of 
SEFL using an astrocyte-specific IL-1 knockout strain or test whether pharmacological or 
genetic astrocyte ablation influences SEFL development. As mentioned in Chapter 1, 
chemogenetic tools under the control of a GFAP promoter are also commercially available and 
experiments described in Chapter 4 will contribute to our understanding of the role of astrocyte 
signaling and fear and anxiety-like behavior using this approach. Thus, while the complete 
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mechanisms involved in astrocyte regulation of stress and anxiety-related behavior remain 
unclear, our data and others’ reports converge to suggest a critical role for astrocytes in 
behavioral responses to stress.  
Given that microglia-derived cytokines are well-established in models of 
neurodegenerative disease, for example, Alzheimer’s and Parkinson’s disease (Sawada, 
Imamura et al. 2006; Block, Zecca et al. 2007; Rogers, Mastroeni et al. 2007), our observation 
of a reduction in microglia is somewhat surprising. While our data are in conflict with several 
reports of stress-induced increases in hippocampal microglia activation or cell count, (Brevet, 
Kojima et al. 2010; Calcia, Bonsall et al. 2016), we are not the first to observe a decrease in 
Iba-1 immunoreactivity following stress. Brzozowska and colleagues reported no change in 
hippocampal microglial cell count but a reduction in microglial cell count in the basolateral 
amygdala 30 days after stress exposure in another foot shock based rodent model of PTSD 
(Brzozowska, Smith et al. 2017). Further, Kreisel and colleagues found that multiple markers 
of microglia, including both Iba-1 and Cd11b mRNA expression and microglia cell count, were 
decreased in the dentate gyrus following five days of chronic unpredictable stress (CUS) 
capable of inducing a depressive-like phenotype (Kreisel, Frank et al. 2014). Interestingly, they 
also showed that after only one day of CUS, these same measures showed an increase in 
microglia gene expression/ immunoreactivity induced by stress. Thus, severity of stressor and 
a longer stress exposure or a later time point after the initial stressor may be critical to our 
observed effect. Nonetheless, the reduction in Iba-1 immunoreactivity observed here further 
supports the notion that astrocytes, not microglia, are organizing important changes in the DH 
following severe stress.  
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We hypothesized that GFAP expression would increase following stress because the 
IL-1β signal is increased in the hippocampus at this time point following stress, and is highly 
colocalized with GFAP. While this hypothesis was not confirmed here, there are several 
potential explanations for our observed lack of effect. First, the amount of GFAP expression 
in the DH (1-1.5% of the region measured) is more than six times that of IL-1β (0.2-0.3% of 
the region measured). Thus, an increase in IL-1β in astrocytes can easily occur without a 
corresponding increase in GFAP. Second, while GFAP is one of the most canonical astrocyte 
markers relied on in the field, GFAP is a cytoskeletal protein that is only expressed within 15% 
of a given astrocyte’s area and even then, only by a subset of astrocytes (Benediktsson, 
Schachtele et al. 2005; Rajkowska and Stockmeier 2013). Measures of GFAP have also yielded 
results that have conflicted with other measures of astrocyte reactivity. Tynan and colleagues 
examined stress-induced changes in astrocyte activation and showed an increase in S100β, 
another astrocyte-specific marker, but a decrease in GFAP following the same stressor (Tynan, 
Beynon et al. 2013). Thus, our measure of GFAP immunoreactivity is an incomplete measure 
of astrocyte reactivity and experiments described in Chapter 3 take advantage of new 
technologies to study astrocyte morphology in greater detail.  
While the sole focus on IL-1 signaling in the current manuscript is well justified given 
previous work supporting the importance of IL-1 signaling in the context of behavioral 
responses to stress (Avital, Goshen et al. 2003; Goshen and Yirmiya 2009; Jones, Lebonville 
et al. 2015), it is important to note that IL-1β does not act in isolation and several other 
proinflammatory mediators may play additional vital roles. For example, both interleukin-6 
(IL-6) and tumor necrosis factor- α (TNF-α) have been shown to be upregulated following 
stress (Audet, Mangano et al. 2010; Barnum, Pace et al. 2012). Studies to examine behavioral 
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implications of stress-induced alterations in additional immune signaling pathways would 
provide more information regarding the specificity of the IL-1 mechanism or could identify 
additional mechanisms that play a role.  
In summary, the data described herein demonstrate that hippocampal IL-1 drives 
important neural changes that render animals hypersensitive to fear learning following stress. 
Further, our data suggest that astrocytes are an important source of hippocampal stress-induced 
IL-1β. These findings provide additional evidence that IL-1 signaling should be considered a 
target for the development of novel therapeutics to treat PTSD and suggest one mechanism 
through which hippocampal astrocytes may influence complex behavior.  
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Chapter 3 
EFFECT OF SEVERE STRESS ON THE MORPHOMETRIC PROPERTIES OF 
HIPPOCAMPAL ASTROCYTES 
Introduction 
The goal of Chapter 3 was to conduct a more thorough analysis of severe stress-induced 
changes in hippocampal astrocyte morphology. Experiments described in Chapter 2 present a 
potential role for astrocytes in the development of SEFL. Specifically, our data provide 
evidence that the predominant source of hippocampal stress-induced IL-1β, which we have 
also shown to be causally related to SEFL, is astrocytes (Figures 2.4 and 2.5). Relatedly, 
astrocytes not only release IL-1 but also express IL-1 receptors, and IL-1β is thought to be a 
potent induction signal for astrocyte activation (Giulian, Woodward et al. 1988; Herx and Yong 
2001; Proescholdt, Chakravarty et al. 2002; John, Lee et al. 2003). As such, stress-induced IL-
1β may, over time, induce further changes in the morphometric properties of astrocytes. While 
we did not observe a stress-induced change in hippocampal GFAP immunoreactivity, as 
described in Chapter 2, others have after a variety of stress protocols (Tynan, Beynon et al. 
2013; Xia, Zhai et al. 2013; Choi, Ahn et al. 2016; Saur, Baptista et al. 2016) and 
inconsistencies in our understanding of hippocampal astrocyte function in the context of 
behavioral responses to stress remain.  
Changes in astrocyte morphology are important to investigate because astrocyte 
morphology and synaptic contact can directly influence astrocyte and neuronal function 
(Montgomery 1994; Blanco-Suarez, Caldwell et al. 2016; Colombo and Farina 2016). 
Converging evidence from multiple laboratories confirms that astrocytes can regulate 
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glutamate homeostasis, synaptic remodeling, secretion of neurotrophic factors, and synaptic 
strength (Ben Menachem-Zidon, Avital et al. 2011; Scofield and Kalivas 2014; Blanco-Suarez, 
Caldwell et al. 2016). In the context of our data, if stress induces an increase in the volume, 
surface area, or synaptic contacts of hippocampal astrocytes, then more IL-1β might reach the 
synapse.  
Current studies that have examined astrocyte morphology following stress have been 
limited by the reliance on  GFAP or S100β immunoassays (Tynan, Beynon et al. 2013; Xia, 
Zhai et al. 2013; Choi, Ahn et al. 2016; Saur, Baptista et al. 2016). As mentioned in Chapter 
2, GFAP constitutes only about 15% of the total volume of an astrocyte and is limited to a 
subset of astrocytes (Benediktsson, Schachtele et al. 2005; Rajkowska and Stockmeier 2013). 
Thus, while these studies do provide support to our hypotheses, they do not provide full 
information about how hippocampal signaling might be influenced by astrocyte changes. For 
example, how fine processes of glial cells that make synaptic contacts are altered following 
stress is unclear from immunoassays of GFAP alone (Scofield, Li et al. 2016).  
Experiments described in the current Chapter will use the novel approach to examine 
astrocyte morphology that is described in Chapter 1. Briefly, Dr. Kathryn Reissner and 
colleagues have optimized a method to isolate and quantify astrocyte volume and synaptic 
contacts throughout a 3-dimensional reconstruction of an individual cell (Scofield, Li et al. 
2016). Their method leads to both reliable and reproducible results, and provides rich detail 
regarding astrocyte morphology that will provide for more information than previous methods 
allowed. This method employs a genetically-encoded, membrane-tagged fluorescent marker to 
allow visualization of the fine peripheral processes of astrocytes (Scofield, Li et al. 2016). High 
resolution confocal microscopy and Bitplane Imaris analyses can be used to employ intensity 
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based thresholding to quantify astrocyte volume, surface area, and colocalization with synaptic 
contacts. Here, we apply this technology in the context of the severe stressor within the SEFL 
paradigm.  
To measure synaptic colocalization, we examined expression of postsynaptic density 
95 (PSD95), an integral protein of the postsynaptic density of primarily excitatory synapses 
which is associated with stabilization of a synaptic contact (Mir, Sen et al. 2014; Berry and 
Nedivi 2017). While PSD95 is strongly associated with NMDA and AMPA receptors, it is not 
exclusively present at excitatory synapses but rather is thought to be a marker of a mature 
synaptic contact (Berry and Nedivi 2017). PSD95 expression in a newly formed spine predicts 
its survival in cultured pyramidal neurons (Taft and Turrigiano 2014; Berry and Nedivi 2017) 
and a reduction in PSD95 in pyramidal neurons is strongly associated with spine retraction 
(Woods, Oh et al. 2011). As such, changes in PSD95 are involved in both hippocampal long 
term potentiation (LTP) and dendritic spine morphology, both of which can predict learning 
and memory performance (Ehrlich and Malinow 2004; Mir, Sen et al. 2014; Serita, Fukushima 
et al. 2017). Given that plasticity and learning involve a degree of spine turnover (Yang, Pan 
et al. 2009; Hayashi-Takagi, Yagishita et al. 2015; Berry and Nedivi 2017), an examination of 
PSD95 levels could provide information regarding learning mechanisms involved in both 
normal fear conditioning or stress-enhanced fear learning. It is also important to note that 
susceptibility to a depression-like phenotype following either social defeat stress or exposure 
to chronic unpredictable mild stress and anxiety-like behavior have been associated with a 
reduction in hippocampal PSD95 (Jianhua, Wei et al. 2017; Kumar and Thakur 2017; Qiao, 
An et al. 2017). Furthermore, Mir and colleagues recently reported one mechanism through 
which IL-1β, which we have shown to be upregulated by stress and causally related to SEFL, 
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can induce a reduction in PSD95 in cortex that is associated with poor performance in the 
rotarod and Morris water maze tests (Mir, Sen et al. 2014). Collectively, while a hypothesis 
regarding the specific memory mechanism involved in mild vs. stress-enhanced fear learning 
would be premature, we hypothesize that the severe stressor in the context of SEFL may be 
associated with a reduction in PSD95. Thus, measuring the levels of PSD95 in the acquired Z 
stacks used for analysis of the morphometric properties of astrocytes is both an important 
control for any implications in terms of astrocyte morphology as well as an interesting 
experimental question.  
Experiments described in the current chapter tested the hypothesis that severe stress 
exposure in the context of the SEFL paradigm influences the morphometric properties of 
astrocytes and the amount of astrocyte synaptic contact in the dorsal hippocampus 48 hours 
later. Regarding PSD95 specifically, we tested the hypothesis that severe stress would decrease 
dorsal hippocampal PSD95 immunoreactivity 48 hours following severe foot shock stress. 
Experiment 3.1 was a brief pilot experiment to ensure that the virus we used was expressed in 
a membrane-dependent manner and was comparable to the viral construct used by Reissner 
and colleagues (Scofield, Li et al. 2016). In Experiment 3.2, an AAV was used to express a 
membrane-dependent fluorescent tag exclusively in hippocampal astrocytes and animals were 
exposed to 15 foot shocks in Context A. Forty-eight hours later, animals were sacrificed such 
that brain tissue could be processed for fluorescence immunohistochemistry, microscopy, and 
high resolution image analysis through Bitplane Imaris such that astrocyte volume, surface 
area, and colocalization with PSD95, as well as PSD95 immunoreactivity, were analyzed.  
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Methods  
Animals  
Male Sprague Dawley rats (225-250 g, Charles River Laboratories, Raleigh, NC) were 
housed individually under a reversed 12 hour light-dark cycle. They were given ad libitum 
access to food and water and were handled regularly throughout all experiments. All 
procedures were conducted in accordance with and approval by the UNC Institutional Animal 
Care and Use Committee.  
Experiment 3.1 Verification of AAV5-GFAP-HA-hM3Dq-IRES-mCitrine as a membrane-
dependent tag 
Viruses 
AAV5-GFAP-HA-hM3Dq(Gq)-IRES-mCitrine was obtained directly from the UNC 
Gene Therapy and Vector Core (Chapel Hill, NC). AAV5-GFAP-Lck-GFP was provided by 
Dr. Kathryn Reissner. Purified viruses were obtained pre-dialyzed (350mM NaCl, 5% D-
sorbitol in phosphate buffered saline), and combined to a single stock containing both viruses 
prior to surgery.  
Surgery and Sacrifice 
Animals (N = 6) were anesthetized with a 1.0 mg/kg intraperitoneal injection of 9:1 
(vol:vol) ketamine hydrochloride (100mg/ml) mixed with xylazine (100 mg/ml). All animals 
were infused with AAV5-GFAP-HA-hM3Dq-IRES-mCitrine and AAV5-GFAP-Lck-GFP. 
Injectors (26 Gauge, Plastics One, Roanoke, VA) were directed bilaterally at the dorsal 
hippocampus (AP -3.4 mm, ML ± 3.1 mm, DV -3.2 mm, 15 degrees, relative to bregma). 
Combined virus was injected in a total volume of 1.4 µl per hemisphere at a rate of 0.1 µl per 
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minute. Injectors were left in place for 15 minutes to allow for diffusion of the virus away from 
the injector site. Three weeks later, all animals were sacrificed via transcardial perfusion. 
Briefly, rats were deeply anesthetized with a 1 ml intraperitoneal injection of 9:1 (vol:vol) 
ketamine hydrochloride (100 mg/ml) mixed with xylazine (100 mg/ml). Animals were 
transcardially perfused with cold 0.1 M phosphate buffer (pH = 7.4) for three minutes at a rate 
of 15 mls/ minute and then with cold 4% paraformaldehyde in 0.1 M phosphate buffered saline 
(pH = 7.4) for seven minutes at a rate of 15 mls/ minute. Brains were extracted and post-fixed 
in 4% paraformaldehyde in 0.1 M phosphate buffered saline for 4–6 hours and then sliced into 
100 µm sections on vibratome.  
Immunohistochemistry 
Immunohistochemical analysis was used to verify that GFAP-hM3Dq was expressed 
in the same membrane-dependent manner as GFAP-Lck-GFP and to verify that both viruses 
were expressed in hippocampal astrocytes and that colocalization with PSD95 could be 
measured. Brain sections were washed three times for 10 minutes in 0.1 M phosphate buffer 
(PB, pH = 7.4) and incubated in 5% Normal Goat Serum and 0.5% TritonX100 for 60 minutes. 
Tissue was then incubated in primary antibody overnight at 4°C in 5% Normal Goat Serum, 
0.5% TritonX100, and rabbit anti-HA (Cell Signaling, Danvers, MA, Cat # mAb3724, 1:500), 
mouse anti-GFAP (1:1000, ThermoFisher Scientific, Waltham, MA, Cat # MS-1376P), or 
mouse anti-PSD95 (1:500, Thermo Fisher Scientific, Waltham, MA, Cat # MA1-045). The 
following day, tissue was washed three times for 10 minutes in 0.1 M PB and incubated in 5% 
Normal Goat Serum, 0.5% TritonX100, and secondary antibody for 120 minutes at room 
temperature. Secondary antibodies conjugated with Alexa-Fluor dyes (Thermo Fisher 
Scientific, Waltham, MA, 1:1000) were used for visualization. Tissue was then washed three 
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times for 10 minutes, mounted onto SuperFrost Plus slides (Fisher Scientific, Pittsburgh, PA) 
and cover slipped using Vectashield hard set mounting medium (Vector Labs, Burlingame, 
CA). For all antibodies, control experiments verified that our staining for all target antigens 
was visible and specific using this method.   
Confocal microscopy and Bitplane Imaris analysis  
A Zeiss LSM800 confocal microscope was used to acquire Z stacks of individual cells 
in the dorsal hippocampus that were transduced by both GFAP-hM3Dq and GFAP-Lck-GFP. 
Z stacks were acquired using a 63X oil immersion lens, 1024 x 1024 frame size, frame average 
of 4, and step size of 0.8 µm. Laser lines that excite at 405nm, 488nm, 561nm were used to 
visualize GFP, and the Alexa Fluor tags used to label GFAP-hM3Dq, GFAP, and PSD95. 
Images were deconvolved using Bitplane AutoQuant X3 (10 iterations, (Lee, Wee et al. 2014)) 
and exported to Bitplane Imaris software (Zurich, Switzerland).  
Experiment 3.2: Effect of stress on the morphometric properties of astrocytes.  
Virus 
AAV5-GFAP-HA-hM3Dq(Gq)-IRES-mCitrine was obtained directly from the UNC 
Gene Therapy and Vector Core (Chapel Hill, NC). Purified virus was obtained pre-dialyzed 
(350mM NaCl, 5% D-sorbitol in phosphate buffered saline) and microinjected at 3.7 x 
1012 particles/ml. 
Surgery 
Animals (N = 16) were anesthetized with a 1.0 mg/kg intraperitoneal injection of 9:1 
(vol:vol) ketamine hydrochloride (100mg/ml) mixed with xylazine (100 mg/ml). All animals 
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were infused with AAV5-GFAP-HA-hM3Dq-IRES-mCitrine. Injectors (26 Gauge, Plastics 
One, Roanoke, VA) were directed bilaterally at the dorsal hippocampus (AP -3.4 mm, ML ± 
3.1 mm, DV -3.2 mm, 15 degrees, relative to bregma). Virus was injected in a volume of 0.7 
µl per hemisphere at a rate of 0.1 µl per minute. Injectors were left in place for 15 minutes to 
allow for diffusion of the virus away from the injector site. Experimental procedures began 
three weeks later.  
Stress exposure and sacrifice 
Animals (N = 16, n = 8) were randomly assigned to either a Foot Shock (in Context A) 
or No Foot Shock (in Context A) treatment and exposed to only the initial severe stressor of 
the SEFL paradigm described in Experiment 2.1. Thus, animals assigned to receive foot shocks 
were exposed to 15 2 mA scrambled foot shocks in Context A, an environment distinct from 
the home cage, while control animals were exposed to the same context without foot shocks 
being delivered. Forty-eight hours after removal from Context A, rats were deeply anesthetized 
with a 1 ml intraperitoneal injection of 9:1 (vol:vol) ketamine hydrochloride (100 mg/ml) 
mixed with xylazine (100 mg/ml). Animals were transcardially perfused with cold 0.1 M 
phosphate buffer (pH = 7.4) for three minutes at a rate of 15 mls/minute and then with cold 4% 
paraformaldehyde in 0.1 M phosphate buffered saline (pH = 7.4) for seven minutes at a rate of 
15 mls/minute. Brains were extracted and post-fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffered saline for 4–6 hours and then sliced into 100 µm sections on vibratome.  
Immunohistochemistry  
The immunohistochemistry protocol was adjusted from that described for Experiment 
3.1 in order to maximize penetration of the antibodies through the 100 µm section. A no 
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primary control stain was used to analyze nonspecific background and ensure analyzed signal 
was specific to the antigens. Brain sections were washed three times for 10 minutes in 0.1 M 
phosphate buffer (PB, pH = 7.4) and incubated in 10% Normal Goat Serum and 2% 
TritonX100 for 60 minutes. Tissue was then incubated in primary antibody for three nights at 
4°C in 10% Normal Goat Serum, 2% TritonX100, and rabbit anti-HA (Cell Signaling, Danvers, 
MA, Cat # mAb3724, 1:500) and mouse-anti-PSD95 (1:500, Thermo Fisher Scientific, Cat # 
MA1-045). The following day, tissue was washed three times for 10 minutes in 0.1 M PB and 
incubated in 10% Normal Goat Serum, 2% TritonX100, and secondary antibody for three 
nights at 4°C. Secondary antibodies conjugated with Alexa Fluor dyes (Thermo Fisher 
Scientific, Waltham, MA, 1:1000) were be used for visualization. Tissue was then washed 3 
times for 10 minutes, mounted onto SuperFrost Plus slides (Fisher Scientific, Pittsburgh, PA) 
and cover slipped using Vectashield Hard Set mounting medium (Vector Labs, Burlingame, 
CA). For all antibodies, control experiments verified that our staining for all target antigens 
was visible and specific using this method.   
Confocal microscopy and Bitplane Imaris analysis  
Image Acquisition 
A Zeiss LSM800 confocal microscope was used to acquire Z stacks of individual cells 
in the dorsal hippocampus that were transduced by AAV5-GFAP-HA-hM3Dq-IRES-mCitrine, 
extended fully through the x, y, and z planes, and were non-overlapping. Acquisition and 
analyses were completed by an experimental blind to treatment group. While the virus was 
expressed throughout the dorsal hippocampus, all of the isolated cells acquired were found in 
CA1 and CA3. Z stacks were acquired using a 63X oil immersion lens, 1024 x 1024 frame 
size, 12 bit image resolution, frame average of 4, and step size of 0.8 µm. Laser lines that excite 
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at 405nm, 488nm, 561nm were used to visualize GFP, and the Alexa Fluor tags used to label 
GFAP-hM3Dq, GFAP, and PSD95. Acquisition parameters including Master Gain, Digital 
Offset and Laser Power were kept the same throughout all acquisition. Images were 
deconvolved using Bitplane AutoQuant X3 (10 iterations, (Lee, Wee et al. 2014)) and exported 
to Bitplane Imaris software (Zurich, Switzerland).  
Astrocyte volume, surface area, and colocalization with PSD95 
Bitplane Imaris software was used to create a 3-D reconstruction of each isolated 
astrocyte (10-15 cells per rat).  Alexa Fluor 488 was used to visualize GFAP-hM3Dq and Alexa 
Fluor 594 was used to visualize PSD95. The surfaces tool was used to generate 3-D 
reconstructions of the astrocyte and both the astrocyte and PSD95 channels were masked to 
the surface such that intensity based colocalization thresholds were used to quantify the 
colocalization with PSD95 in each cell in the Colocalization tab. Ten random samples of the 
absolute intensity of the PSD95 signal through the Z stack were recorded and the mean 
intensity was used to set the colocalization threshold. A two-dimensional scatter plot was used 
to visually inspect the accuracy of colocalization thresholds. The region of interest (ROI) was 
defined as the astrocyte within the Z stack by masking the colocalization data to the surface of 
the GFAP-hM3Dq channel. For all analyses, astrocyte surface area, astrocyte volume, and % 
ROI colocalized with PSD95 were recorded. Each image was also visually inspected to ensure 
that all cells included in the final analysis were non-overlapping, extended fully through the x, 
y, and z planes, and that the PSD95 signal was at least 6-fold greater than background detected 
in the no primary antibody control stain in all Z stacks used for colocalization analysis. Any 
animal from which fewer than four cells meeting these criteria were able to be acquired from 
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the dorsal hippocampus was dropped from the analysis, and any such decision was made blind 
to treatment group.  
Quantification of hippocampal PSD95 immunoreactivity  
PSD95 immunoreactivity in each of the acquired Z stacks was quantified. A no primary 
antibody control stain revealed that the secondary incubation was associated with a non-
specific band of signal towards the edge of the tissue. This portion of the Z stack was cut from 
the analysis manually by an experimenter blind to treatment group. Ten random samples of the 
absolute intensity of the PSD95 signal through the Z stack were recorded and the mean 
intensity was used to set the absolute intensity threshold. Again, care was taken to ensure that 
the PSD95 signal was at least 6-fold greater than background detected in the no primary 
antibody control stain in all Z stacks included in the analysis.  The ROI was defined as the 
whole Z stack and the % ROI with voxels above the absolute intensity threshold determined 
was recorded.  
Statistical Analysis  
For Experiment 3.2, two tailed unpaired student’s t tests were used to test the effect of 
foot shock on astrocyte volume, surface area, and the %ROI colocalized with PSD95. A one 
tailed unpaired student’s t test was used to test the effect of foot shock on the %volume of 
PSD95. 
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Results  
Experiment 3.1 AAV5-GFAP-HA-hM3Dq-IRES- -mCitrine is expressed in a membrane-
dependent manner 
Confocal Z stacks of co-transduced cells that were deconvolved and exported to 
Btiplane Imaris were visually inspected for colocalization of GFAP- hM3Dq and GFAP-Lck-
GFP signals and for colocalization with GFAP and PSD95. GFAP-Lck-GFP (and GFAP-
hM3Dq)-positive cells colocalized with GFAP in the dorsal hippocampus, confirming that 
astrocytes were effectively targeted, and with PSD95, confirming that this method can be used 
to quantify astrocyte synaptic contacts (Figure 3.1). In hippocampal astrocytes transduced by 
both GFAP-hM3Dq and GFAP-Lck-GFP, there was clear colocalization such that GFAP-
hM3Dq was expressed in the fine, distal processes of astrocytes in a manner identical to GFAP-
Lck-GFP (Figure 3.2). Thus, for Experiment 3.2, GFAP-hM3Dq was used to quantify the 
morphometric properties and synaptic contacts of astrocytes following stress.  
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Figure 3.1 GFAP-LcK-GFP is expressed selectively in astrocytes. GFAP-Lck-GFP 
colocalizes with GFAP, an astrocyte-specific marker (A) and can be visualized with PSD95, a 
synaptic marker, (B) to quantify astrocyte synaptic contact.  
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Figure 3.2 GFAP-hM3Dq can be used to examine astrocyte morphology. The glial Gq 
DREADD construct GFAP-hM3Dq (A) colocalized with GFAP-Lck-GFP (B), suggesting that 
GFAP-hM3Dq is also expressed in a membrane-dependent manner and can be used for high 
resolution analyses of the morphometric properties and synaptic colocalization of hippocampal 
astrocytes. Confocal Z stacks were acquired using a 63X oil immersion lens, deconvolved 
using AutoQuantX and masked to the astrocyte volume using Bitplane Imaris. The merged 
image of both signals (C) shows complete colocalization, which is confirmed by an image of 
Imaris-generated colocalized voxels within the Z stack (D).  
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Experiment 3.2: Effect of stress on the morphometric properties of astrocytes.  
Stress exposure does not alter astrocyte volume, surface area or colocalization with PSD95 
There was no effect of foot shock on astrocyte volume, t (11) = 0.8686, p = 0.8686, or 
surface area, t (11) = 0.05384, p = 0.9580. There was also no effect of foot shock on the %ROI 
colocalized with PSD95, t (8) = 1.394, p = 0.2008. These data as well as representative images 
of a 3-D reconstruction of an astrocyte co-labeled with PSD95 from each treatment group are 
presented in Figure 3.3.  
As we have previously published data to suggest that stress-induced IL-1β is most 
dense in the dentate gyrus of the dorsal hippocampus (Jones, Lebonville et al. 2015), it is 
important to note that all of the cells that met the criteria for analysis were acquired from CA1 
and CA3 (Figure 3.4). Because virus expression was very dense in this region (Figure 3.4), 
there were no cells that were non-overlapping and extended fully through the x, y, and z planes 
in this region. 
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Figure 3.3 Foot shock does not alter the morphometric properties of astrocytes. Bitplane 
Imaris software was used to calculate the volume (A) and surface area (B) of hippocampal 
astrocytes 48 hours following severe stress in Context A. There was no effect of foot shock on 
either volume or surface area. (D) Representative cells that were colabeled with PSD95 from 
both the stressed (Foot Shock) and non-stressed (No Foot Shock) groups are shown. (C) In 
addition to volume and surface area analysis, synaptic contact was measured by calculating 
colocalization of each cell acquired with PSD95 and there was no effect of foot shock on the 
%ROI colocalized. (E) Imaris-generated images of the colocalized voxels within each Z stack 
from the representative images are also shown. *ns = not significant, p > 0.05.  
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Figure 3.4 Cells included in morphology analyses were predominantly from CA1 and 
CA3. (A) Dense GFAP-hM3Dq expression in the dentate gyrus of the dorsal hippocampus 
prevented the acquisition of isolated/ non-overlapping cells. As such, all acquisition occurred 
in the CA1 and CA3 subregions of the dorsal hippocampus. (A) A representative image 
acquired at 10X is presented. (B) Outlines represent the approximate areas of CA1 and CA3 
were most cells included in the analysis were acquired. Coordinates are relative to Bregma. 
(Paxinos and Watson, 2007) 
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Stress exposure attenuates PSD95 Immunoreactivity 
As shown in Figure 3.5, foot shock attenuated PSD95 immunoreactivity, t (8) = 1.883, 
p = 0.482. Thus, the slight mean difference observed suggesting a decrease in astrocyte 
colocalization with PSD95 in Figure 3.3 is confounded by the fact that foot shock induced a 
decrease in the PSD95 signal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Foot shock attenuated PSD95 immunoreactivity. PSD95 was quantified in Z 
stacks of individual astrocytes acquired using Bitplane Imaris (C). Representative images from 
non-stressed (A) and stressed (B) rats acquired using a 63X oil immersion lens are shown. 
Bitplane Imaris was used to subtract background prior to quantification thresholding, and as 
such, thresholded images are shown. Again, the areas of CA1 and CA3 in the dorsal 
hippocampus were there images were acquired are presented (D). Coordinates are relative to 
Bregma. (Paxinos and Watson, 2007) 
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Discussion 
The hypothesis that severe stress induces changes in the morphometric properties of 
astrocytes 48 hours later was not supported here. There was no change induced by foot shock 
exposure in Context A in hippocampal astrocyte volume, surface area, or colocalization with 
PSD95. However, we observed a significant decrease in PSD95 immunoreactivity. The 
interesting implications of a stress-induced decrease in hippocampal PSD95 are discussed 
below.  
It is important to note that dynamic stress-induced changes in astrocyte morphology 
may make critical time points for this variable difficult to pinpoint. While important to 
examine, 48 hours post-stress is not the only time point at which changes in astrocyte 
morphology might be important to SEFL and may represent a very short time point relative to 
the initial manipulation. Reissner and colleagues have reported changes in nucleus accumbens 
astrocyte morphology that were measured following 14-16 days of extinction after self-
administration of cocaine (Scofield, Li et al. 2016).  A later time point in the SEFL model 
might allow us to detect changes in the morphometric properties of astrocytes that occur on a 
slower timeline. For example, examining astrocyte morphology seven days after Context A 
exposure would give us a measure of astrocyte morphology at the time at which conditioning 
in Context B would normally take place, and thus the time at which stress-induced changes in 
plasticity are important for processing future stressors.  
The specific learning and memory mechanisms through which a previous stressor can 
render animals hypersensitive to future fear learning are unknown. We have shown that both 
IL-1RA (Chapter 2, (Jones, Lebonville et al. 2015)) and morphine (Szczytkowski-Thomson, 
Lebonville et al. 2013) are sufficient to influence the development of SEFL. However, given 
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that PSD95 is important for the stabilization of new synaptic contacts, a reduction in PSD95 
could be involved in a stress-induced change in dendritic morphology or the rate of spine 
turnover as another mechanism that is important for this effect (Berry and Nedivi 2017). 
Interestingly, Qiao and colleagues recently reported that an injection of Brain Derived 
Neurotrophic Factor (BDNF) rescued chronic mild unpredictable stress-induced deficits in 
hippocampal dendritic spine density and PSD95 (Qiao, An et al. 2017). Indeed, BDNF function 
has been implicated in both rodent models of PTSD (Ji, Peng et al. 2017; Lee, Shim et al. 2017) 
and human PTSD (Rakofsky, Ressler et al. 2012; Green, Corsi-Travali et al. 2013), further 
supporting the hypothesis that a better understanding of synaptic remodeling in the 
hippocampus in this context is important. Thus, while the stress-induced reduction in PSD95 
should be replicated using multiple methods of measurement and a larger region of tissue 
sample given that the area we measured was limited to Z stacks of 8-10 cells per rat, our data 
suggest that attention to synaptic remodeling and spine turnover in the context of SEFL could 
lead to promising discoveries.  
The main advantage of our approach in the current chapter was that the membrane-
dependent tag allowed us to visualize and quantify the most distal perisynaptic processes of an 
astrocyte that position the cell perfectly to interact with synaptic transmission (Blanco-Suarez, 
Caldwell et al. 2016; Scofield, Li et al. 2016). Thus, despite the fact that we did not detect 
differences in the morphometric properties of astrocytes 48 hours  post-stress, given that a 
reduction in PSD95 could be associated with spine retraction or the presence of more immature 
spine s(Berry and Nedivi 2017), neurotrophic factors secreted by astrocytes, such as BDNF or 
glial cell-derived neurotrophic factor (GDNF) (Hassanpoor, Fallah et al. 2014; Hisaoka-
Nakashima, Miyano et al. 2015; Hisaoka-Nakashima, Matsumoto et al. 2017) could still have 
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a meaningful impact on memory mechanisms in the hippocampus following stress. This 
hypothesis is discussed further in Chapter 5. As discussed in more detail in Chapter 4, 
astrocyte-specific manipulations have been shown to be involved in behavioral outcomes 
following a variety of different stress protocols (Ben Menachem-Zidon, Avital et al. 2011; Xia, 
Zhai et al. 2013; Levkovitz, Fenchel et al. 2015). Furthermore, our data presented in Chapter 
2 strongly suggest that important changes do occur in astrocytes in terms of cytokine 
expression. The experiments described in Chapter 4 use a second novel approach to further 
explore hippocampal astrocyte function in the context of SEFL.  
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Chapter 4 
EFFECT OF HIPPOCAMPAL ASTROGLIAL GI SIGNALING ON STRESS-ENHANCED 
FEAR LEARNING 
Introduction 
Astroglial signaling is an innovative field of neuroscience that is underrepresented in 
the current literature. Converging evidence is beginning to suggest an important role for 
astroglial signaling in a complex behavior (Barres 2008; Rial, Lemos et al. 2015)  and several 
laboratories have suggested that potential treatments that improve behavioral outcomes of 
PTSD may have acted through glial-dependent mechanisms (Ben Menachem-Zidon, Avital et 
al. 2011; Xia, Zhai et al. 2013; Levkovitz, Fenchel et al. 2015). Xia and colleagues identified 
one compound that showed promise to alleviate PTSD-like symptoms following single 
prolonged stress, Fibroblast growth factor-2 (FGF2), which also prevented stress-induced 
changes in GFAP expression (Xia, Zhai et al. 2013). Further, Menachem-Zidon and colleagues 
demonstrated that astrocytes can influence fear learning through an IL-1β – dependent 
mechanism in that the introduction of neural precursor cells which ultimately differentiated 
into astrocytes rescued deficits in fear conditioning traditionally observed in an IL-1 receptor 
knock out line (Ben Menachem-Zidon, Avital et al. 2011). While the complete mechanisms 
involved in each of these effects remain unclear, they suggest that astroglial signaling is 
important in PTSD and merits further study.  The goal of the experiments described in the
current chapter was to examine the development of SEFL following direct manipulation of 
hippocampal astroglial GPCR signaling. 
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Chapter 2, as well as our previously published report (Jones, Lebonville et al. 2015), 
show that hippocampal IL-1β is expressed by hippocampal astrocytes and is causally related  
to SEFL. Given that IL-1β is both a potent stimulator of astrocytes as well as secreted by 
astrocytes, directly manipulating astrocytes in the context of enhanced fear learning represents 
an important area of research. GPCR signaling in astrocytes is a good target for such 
experiments in that IL-1β expression is known to be regulated by GPCR signaling in the central 
nervous system. Specifically, second messengers downstream of Gi activation have been 
linked to the regulation of IL-1β in that Jin and colleagues observed a reduction in LPS-induced 
IL-1β protein following the application of a PKA inhibitor (Jin, Sato et al. 2014). Furthermore, 
Nuclear factor kB (NFkB) is a critical component of inflammatory astroglial signaling (Ben 
Menachem-Zidon, Avital et al. 2011) that regulates IL-1β (Cogswell, Godlevski et al. 1994) 
and is known to be directly regulated by GPCR signaling (Ye 2001). Lastly, morphine, a 
systemic treatment known to reduce both SEFL and PTSD (Holbrook, Galarneau et al. 2010; 
Nixon, Nehmy et al. 2010; Szczytkowski-Thomson, Lebonville et al. 2013; Melcer, Walker et 
al. 2014) and to attenuate stress-induced IL-1β (Jones, Lebonville et al. 2015), activates Gi- 
coupled signaling via activation of the µ opioid receptor (Convertino, Samoshkin et al. 2015). 
As mentioned in Chapter 1, technological limitations have previously prevented 
researchers from selectively isolating astrocyte signaling pathways. Recent innovations, such 
as designer receptors exclusively activated by designer drugs (DREADDs), have overcome 
this limitation. DREADDs are engineered muscarinic receptors that have no endogenous 
ligand but can be activated by an otherwise physiologically inert compound, clozapine-N-
oxide (CNO) (Zhu and Roth 2014). Dr. Bryan Roth (UNC Chapel Hill) has designed viral 
constructs for Gi- coupled DREADD receptors under the astrocyte-specific promoter, GFAP. 
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Impressively, these advances in chemogenetics have allowed researchers to manipulate 
astroglial GPCR signaling in vivo, and four groups have shown that manipulating astrocytes 
in the CNS directly influences behavioral outcomes (Agulhon, Boyt et al. 2013; Bull, Freitas 
et al. 2014; Scofield, Boger et al. 2015; Yang, Qi et al. 2015).  Experiments described in the 
current chapter took advantage of this technology to selectively activate Gi signaling 
specifically in astrocytes within the dorsal hippocampus in the context of SEFL.  
It is important to note that glial-expressing DREADD constructs are still new and, to 
our knowledge, only one effect has been reported with the AAV8-GFAP-hM4Di-mCherry to 
date (Yang, Qi et al. 2015). Yang and colleagues reported that hypothalamic astroglial Gi 
activation enhanced ghrelin-evoked food intake. In the same report, they also showed that 
hypothalamic astroglial Gq activation attenuated ghrelin-evoked food intake. In an effort to 
verify both of the glial DREADD constructs the group used, they also reported that CNO 
administration enhanced GFAP colocalization with cFos, an immediate early gene, only in 
AAV-GFAP-hM3Dq-mCherry-transduced rats and not in AAV-GFAP-hM4Di-mCherry 
transduced- rats (Yang, Qi et al. 2015). Thus, while their virus-specific and CNO-specific 
enhancement of feeding and GFAP colocalization with cFos are supportive of the validity of 
GFAP-hM4Di, there are no published data reported to directly confirm that CNO activates Gi-
coupled signaling when used with this construct.   
In an effort to provide support for the validity of this important tool in neuroscience,   
in a subset of animals in Experiment 4.1, we also used high resolution confocal microscopy to 
measure the colocalization of the mCherry signal in AAV8-GFAP-hM4Di-mCherry-tranduced 
hippocampal astrocytes with cyclic adenosine monophosphate (cAMP), a Gi-dependent 
signaling marker. Of note, given that Gi-coupled signaling is typically inhibitory in nature, it 
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is possible that a floor effect may confound attempts to verify the hM4Di construct in naïve 
animals. To account for this, animals selected for this assay were also injected with 
lipopolysaccharide (LPS, derived from E. coli) to induce a state of central neuroinflammation 
in which we might be better able to detect CNO-induced changes in Gi-dependent messengers, 
such as cAMP, in astrocytes (Tarassishin, Suh et al. 2014).  
Collectively, the goal of experiments described in the current chapter was to test the 
hypothesis that hippocampal astroglial Gi signaling is sufficient to attenuate SEFL. Experiment 
4.1 used AAV8-GFAP-hM4Di-mCherry to selectively activate astroglial Gi signaling in the 
hippocampus at 1 mg/kg or 3 mg/kg CNO in SEFL. Experiment 4.2 used fluorescence 
immunohistochemistry, confocal microscopy, and Bitplane Imaris colocalization analysis to 
examine cAMP expression in GFAP-hM4Di-mCherry-positive astrocytes following LPS and 
CNO or Vehicle injection.  
Methods 
Animals  
Male Sprague Dawley rats (225-250 g, Charles River Laboratories, Raleigh, NC) were 
housed individually under a reversed 12 hour light-dark cycle. They were given ad libitum 
access to food and water and were handled regularly throughout all experiments. All 
procedures were conducted in accordance with and approval by the UNC Institutional Animal 
Care and Use Committee.  
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Virus 
AAV8-GFAP-hM4Di(Gi)-mCherry was obtained directly from the UNC Gene 
Therapy and Vector Core (Chapel Hill, NC). Purified virus was obtained pre-dialyzed (350mM 
NaCl, 5% D-sorbitol in phosphate buffered saline) and microinjected at 2.0 x 1012 particles/ml. 
Surgery  
Animals (N = 64, n = 8) were anesthetized with a 1.0 mg/kg intraperitoneal injection 
of 9:1 (vol:vol) ketamine hydrochloride (100mg/ml) mixed with xylazine (100 mg/ml). All 
animals were infused with AAV8-GFAP-hM4Di-mCherry. Injectors (26 Gauge, Plastics One, 
Roanoke, VA) were directed bilaterally at the dorsal hippocampus (AP -3.4 mm, ML ± 3.1 
mm, DV -3.2 mm, 15 degrees, relative to bregma). Virus was injected in a volume of 0.7 µl 
per hemisphere at a rate of 0.1 µl per minute. Injectors were left in place for 15 minutes to 
allow for diffusion of the virus away from the injector site. Experimental procedures started 
three weeks later.  
Experiment 4.1: Effect of hippocampal astroglial Gi activation on SEFL  
Stress-enhanced fear learning  
The SEFL procedure used for Experiment 4.1 is identical to that described in Chapter 
2. Two cohorts of animals were run, the first tested the effect of 1 mg/kg CNO (N = 32, n = 8) 
and then second tested the effect of 3 mg/kg CNO (N = 32, n = 8). Briefly, all animals were 
randomly assigned to a Context A treatment (Foot Shock in Context A or No Foot Shock in 
Context A) and a drug treatment (CNO or vehicle) and exposed to the SEFL paradigm (Figure 
4.1),  as has been previously published (Szczytkowski-Thomson, Lebonville et al. 2013; Jones, 
Lebonville et al. 2015). Rats were injected with CNO (1 mg/kg or 3 mg/kg subcutaneously) or 
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vehicle immediately, 24, and 48 hours after removal from Context A. Contextual fear to 
Context B was measured by analyzing freezing behavior at baseline and on test days 1, 2, 7, 
and 14. Behavior was recorded as described in Chapter 2 and analyzed manually by a rater 
blind to the treatment group. Similar to Experiment 2.1, there was no significant generalization 
of fear between contexts in any treatment group (Results of Experiment 4.1), thus any 
differences observed reflect altered learning to the single shock in Context B.  
 
 
Figure 4.1 Experimental timeline for Experiment 4.1. Rats were infused with AAV8-
GFAP-hM4Di-mCherry bilaterally into the dorsal hippocampus, given three weeks to recover, 
and exposed to the SEFL paradigm. Rats were injected with CNO or vehicle (1 or 3mg/kg) 
immediately, 24, and 48 hours after Context A exposure.  
 
Drug Administration 
CNO was obtained from Sigma (St. Louis, MO) and was reconstituted at 3 mg/ml or 1 
mg/ml in sterile saline with 0.5% dimethyl sulfoxide (DMSO). Animals were injected 
subcutaneously (s.c.) with 1 mg/kg or 3 mg/kg CNO or vehicle (sterile saline with 0.5% 
DMSO) at the times indicated above.  
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Sacrifice 
All animals were sacrificed via transcardial perfusion. Briefly, rats were deeply 
anesthetized with a 1 ml intraperitoneal injection of 9:1 (vol:vol) ketamine hydrochloride (100 
mg/ml) mixed with xylazine (100 mg/ml). Animals were transcardially perfused with cold 0.1 
M phosphate buffer (pH = 7.4) for three minutes at a rate of 15 mls/minute and then with cold 
4% paraformaldehyde in 0.1 M phosphate buffered saline (pH = 7.4) for seven minutes at a 
rate of 15 mls/minute. Brains were extracted and post-fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffered saline for 4–6 hours, cryoprotected in 30% sucrose in 0.1 M phosphate 
buffer (pH = 7.4) for at least 48 hours, and sliced into 40 µm sections on freezing microtome. 
Brains were stored in 0.1 M phosphate buffer with 0.1% sodium azide (pH = 7.4) at 4°C until 
the time of assay. 
Immunohistochemistry  
Fluorescence immunohistochemistry was used to ensure that all virus expression was 
astrocyte- and hippocampus-specific. Brain sections were washed three times for 10 minutes 
in 0.1 M phosphate buffer (PB, pH = 7.4) and incubated in 5% Normal Goat Serum and 0.5% 
TritonX100 for 60 minutes. Tissue was then incubated in primary antibody overnight at 4°C 
in 5% Normal Goat Serum, 0.5% TritonX100, and mouse anti-GFAP (1:1000, ThermoFisher 
Scientific, Waltham, MA, Cat #MS-1376P), or mouse anti-NeuN (1:1000, Abcam, Cambridge, 
MA, Cat# Ab207282). The following day, tissue was washed three times for 10 minutes in 0.1 
M PB and incubated in 5% Normal Goat Serum, 0.5% TritonX100, and secondary antibody 
for 120 minutes at room temperature. Secondary antibodies conjugated with Alexa-Fluor dyes 
(1:1000, Thermo Fisher Scientific, Waltham, MA) were used for visualization. Tissue was then 
washed three times for 10 minutes, mounted onto SuperFrost Plus slides (Thermo Fisher 
70 
 
Scientific, Waltham, MA) and cover slipped using Vectashield hard set mounting medium 
(Vector Labs, Burlingame, CA). For all antibodies, control experiments verified that our 
staining for all target antigens was visible and specific using this method.  Slides were stored 
at 4°C until the time of microscopy. A Zeiss LSM800 confocal microscope was used to ensure 
that mCherry colocalized with GFAP, and not with NeuN, and thus was specific to astrocytes. 
Only data from animals with virus expression that was both hippocampus- and astrocyte- 
specific were included in the final analyses.  
Experiment 4.2: Effect of CNO on colocalization of mCherry-positive cells with cAMP 
Sacrifice 
After the completion of behavioral testing for Experiment 4.1, two rats from the No 
Foot Shock in Context A/ Vehicle group were randomly selected for a pilot experiment which 
aimed to verify that CNO activated Gi—coupled signaling in mCherry-positive cells. Both rats 
selected were injected with Lipopolysaccharide (LPS; derived from E. coli, serotype 055:B5) 
in order to induce central neuroinflammation and CNO to activate GFAP-hM4Di prior to 
sacrifice by transcardial perfusion described above. LPS was dissolved in sterile 0.9% saline 
at 1.0 mg/ml and CNO was dissolved as described above. Three hours and thirty minutes prior 
to sacrifice, one rat was injected with CNO (3 mg/kg, s.c.) and the other was injected with 
vehicle. Thirty minutes after CNO or vehicle injection, both rats were injected with 1 mg/kg 
LPS. Rats were sacrificed via transcardial perfusion three hours after the LPS injection. 
Experimental timeline is shown in Figure 4.2.  
 
 
71 
 
 
 
 
 
 
 
Figure 4.2 Experimental timeline for Experiment 4.2. A subset of animals from Experiment 
4.1, that had been bilaterally infused with AAV8-GFAP-hM4Di-mCherry into the dorsal 
hippocampus, were injected with CNO or vehicle (3 mg/kg, s.c.) and 30 minutes later were 
injected with LPS (1mg/kg, s.c.). Three hours later, animals were sacrificed by transcardial 
perfusion and brains were extracted and processed for immunohistochemistry.  
 
Immunohistochemistry  
In addition to the immunohistochemistry for virus verification describe above, 
additional tissue from the animals in Experiment 4.2 was stained for colocalization analysis of 
mCherry and cAMP. Briefly, sections were washed three times for 10 minutes in 0.1 M 
phosphate buffer (PB, pH = 7.4) and incubated in 5% Normal Goat Serum and 0.5% 
TritonX100 for 60 minutes. Tissue was then incubated in primary antibody overnight at 4°C 
in 5% Normal Goat Serum, 0.5% TritonX100, and mouse anti-cAMP (1:1000, Abcam, 
Cambridge, MA, Cat # ab24851). The following day, tissue was washed three times for 10 
minutes in 0.1 M PB and incubated in 5% Normal Goat Serum, 0.5% TritonX100, and goat 
anti-mouse Alexa Fluor 488 (1:1000, Thermo Fisher Scientific, Waltham, MA, Cat # A11001) 
for 60 minutes at room temperature. Tissue was then washed 3 times for 10 minutes, mounted 
onto SuperFrost Plus slides (Thermo Fisher Scientific, Waltham, MA) and cover slipped using 
Vectashield hard set mounting medium (Vector Labs, Burlingame, CA). Slides were stored at 
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-20°C until the time of assay. In addition, as for all other antibodies used, no primary control 
experiments verified the specificity of the anti-cAMP signal.  
Confocal microscopy and Bitplane Imaris colocalization analysis 
Image Acquisition 
A Zeiss LSM800 confocal microscope was used to acquire Z stacks of individual cells 
in the dorsal hippocampus that were transduced by AAV8-GFAP-hM4Di-mCherry. 
Acquisition and analyses were completed by an experimenter blind to treatment group. Z 
stacks were acquired using a 63X oil immersion lens, 1024 x 1024 frame size, 12 bit image 
resolution, frame average of 4, and step size of 0.8 µm. Laser lines that excite at 488nm, 561nm 
were used to visualize Alexa Fluor 488 and the mCherry signal. Acquisition parameters 
including Master Gain, Digital Offset and Laser Power were kept the same throughout all 
acquisition. Images were deconvolved using Bitplane AutoQuant X3 (10 iterations, (Lee, Wee 
et al. 2014)) and exported to Bitplane Imaris software (Zurich, Switzerland).  
Colocalization of mCherry and cAMP 
Bitplane Imaris software was used to create a 3-D reconstruction of each mCherry-
positive astrocyte (20 cells per rat).  The surfaces tool was used to set absolute intensity 
thresholds for both the mCherry and cAMP signals that were used for colocalization analyses 
in the colocalization tab.  A two-dimensional scatter plot was used to visually inspect the 
accuracy of colocalization thresholds. The region of interest (ROI) was defined as the mCherry 
reconstruction within the Z stack by masking the colocalization data to the surface of the 
mCherry channel. As such, the %ROI colocalized represents the percent of voxels within the 
mCherry reconstruction that were also above the threshold for the cAMP signal. The %ROI 
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colocalized was recorded. In addition, to avoid a potential confounding floor effect given that 
we expected CNO to reduce cAMP in mCherry-positive cells, cells from both treatment groups 
that exhibited less than 10% colocalization were dropped from the analysis. Seven cells from 
the CNO-treated group and eight cells from the vehicle-treated group were dropped for this 
reason.  
Statistical Analysis  
For Experiment 4.1, data from the two experiments (1 mg/kg vs. 3mg/kg CNO) were 
analyzed independently. For each experiment, a one way ANOVA with treatment group as the 
between subjects factor was used to analyze baseline freezing data during the three minutes 
prior to the foot shock during Context B conditioning in order to ensure there were no group 
differences in freezing to Context B prior to the single shock. A 2 x 2 x 4 repeated measures 
ANOVA with Context A treatment and drug treatment as between subject factors and test day 
as a within subjects factor was used to analyze freezing behavior across test days 1, 2, 7 and 
14. Significant interactions were examined using Tukey’s post-hoc comparisons. Specifically, 
planned comparisons included: Foot shock in Context A/ Vehicle vs. Foot shock in Context A/ 
CNO and No Foot shock in Context A/ Vehicle vs. Foot shock in Context A/ Vehicle. For 
Experiment 4.2, a one tailed student’s t test was used to test the effect of drug treatment on the 
%ROI colocalized.  
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Results 
Experiment 4.1: Hippocampal astroglial Gi activation attenuates SEFL  
GFAP-hM4Di was selectively expressed in hippocampal astrocytes and we observed a 
dose-dependent and CNO-specific effect of CNO on the development of SEFL (Figure 4.3). 
There was no effect of Context A treatment on baseline freezing in Context B prior to the single 
shock ineither the cohort that tested the effect of 1 mg/kg CNO, F (3, 14) = 1.028, p = 0.410, 
or the cohort that tested the effect of 3 mg/kg F (3, 16) = 2.034, p = 0.150. Thus, there was no 
generalization of fear between the two contexts in either experiment. A 2 x 2 x 4 ANOVA 
revealed a significant main effect of Context A treatment, F (1, 14) = 7.092, p = 0.019, and 
significant main effect of test day, F (3, 14) = 36.221, p < 0.001, for the cohort that tested the 
effect of 1 mg/kg CNO. However, there was no effect of 1 mg/kg CNO on SEFL in that there 
was no main effect of drug treatment, F (1,14) = 0.476, p = 0.501, and no Context A treatment 
by drug treatment interaction F (1,14) = 0.613, p = 0.447. Tukey’s post hoc tests confirmed 
that there was significant SEFL in that rats that received Foot Shock in Context A followed by 
vehicle exhibited enhanced fear to Context B compared to rats that received No Foot Shock in 
Context A followed by vehicle, p = 0.011.   
For the cohort that tested the effect of 3 mg/kg CNO, again there was a significant main 
effect of Context A treatment, F (1,16) = 16.228, p = 0.001, and a significant main effect of 
test day, F (3,16) = 39.277, p < 0.001. Tukey’s post hoc comparisons confirmed a significant 
SEFL effect in that, again, rats that received Foot Shock in Context A followed by vehicle 
exhibited enhanced fear to Context B compared to rats that received No Foot Shock in Context 
A followed by vehicle, p < 0.001. In addition, there was a significant effect of 3 mg/kg CNO 
on SEFL in that there was a significant main effect of drug treatment F (1,16) = 5.213, p = 
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0.036. Tukey’s post hoc comparisons confirmed that 3 mg/kg CNO significantly attenuated 
SEFL in that rats that received Foot Shock in Context A followed by CNO exhibited attenuated 
freezing to Context B compared to rats that received Foot Shock in Context A followed by 
vehicle, p = 0.015. 
 
Figure 4.3 Astoglial Gi activation attenuates stress-enhanced fear learning. GFAP-hM4Di-
mCherry was expressed selectively in hippocampal astrocytes. Representative images acquired 
using a 10X and 63X oil immersion lens are shown. GFAP-hM4Di-mCherry colocalized 
exclusively with hippocampal GFAP/astrocytes (A,C) and did not colocalize with NeuN (B,D). 
Activation of hippocampal astroglial Gi signaling attenuated stress-enhanced fear learning at 3 
mg/kg (E) but not 1 mg/kg (F) CNO. Specifically, enhanced fear learning was observed in that 
stressed animals who received vehicle exhibited significantly more freezing to Context B than 
non-stressed animals that received vehicle, p < 0.01, for both 1 and 3 mg/kg CNO. 
Furthermore, CNO attenuated SEFL in that stressed animals that received 3 mg/kg CNO 
exhibited attenuated freezing to Context B compared to stressed animal that received vehicle, 
p < 0.05. * Foot Shock in Context A/Vehicle vs. Foot Shock in Context A/ CNO, p < 0.05.  
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Experiment 4.2: CNO attenuated colocalization of mCherry-positive cells with cAMP 
CNO treatment significantly attenuated cAMP in mCherry-positive hippocampal 
astrocytes (Figure 4.4). There was a significant effect of CNO on the %ROI colocalized, t (22) 
= 2.495, p = 0.0103.  
 
 
 
Figure 4.4 CNO attenuates cAMP in GFAP-hM4Di-mCherry -transduced cells. LPS was 
used as an inflammatory stimulator and hippocampal mCherry positive cells were analyzed for 
colocalization with cAMP immunoreactivity. Z stacks using a 63x oil immersion lens of 20 
cells per group were acquired and analyzed using Bitplane Imaris. The ROI was defined as all 
voxels within the Z stack that expressed mCherry and the %ROI colocalized for each virus-
transduced cell was generated. Three mg/kg CNO significantly attenuated the %ROI 
colocalized with cAMP (the % of mCherry-positive voxels that were also positive for cAMP) 
(A). Representative scatter plots show the distribution of voxels in a representative Z stack 
from each group (B,C). Each point on the scatter plot represents one voxel in the Z stack, the 
X axis represents the mCherry intensity and the Y axis represents the cAMP (Alexa Fluor 488) 
intensity. A low magnification example image (acquired at 10X) shows the cAMP and 
mCherry signals in the dorsal hippocampus. A representative cell from the CNO (E) and 
Vehicle (F) groups are presented along with the masked cAMP signal (signal above the 
absolute intensity threshold and within the defined ROI/ mCherry-positive voxels). Bitplane 
Imaris-generated colocalization panels show the %ROI Colocalized within each Z stack.  
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Discussion 
Here, we found that 3 mg/kg, but not 1 mg/kg, CNO attenuated the development of 
SEFL in GFAP-hM4Di infused animals. This dose-dependent and CNO-specific effect 
provides strong evidence that hippocampal astroglial Gi signaling is sufficient to attenuate 
SEFL. Furthermore, we are the first to show that CNO significantly attenuated cAMP in 
GFAP-hM4Di-mCherry-positive cells.  
The verification of new technologies is critically important to the field of neuroscience. 
Our data show that CNO influences a Gi-dependent signaling pathway as expected in AAV8-
GFAP-hM4Di-mCherry-transduced hippocampal astrocytes. However, these data are limited 
both by the fact that only two animals were used and the mCherry signal is not expressed 
throughout the whole astrocyte, making colocalization less precise in that we were limited to 
only mCherry-positive voxels in any given z stack. Future studies should examine cAMP post-
CNO in a larger sample of animals, and should examine other Gi-dependent second 
messengers, such as Protein Kinase A (PKA), as well.  
It is also important to note that these data would be greatly strengthened by an 
experiment using a control virus for the construct used (AAV8-GFAP-EGFP), as a recent 
report suggests that CNO may be associated with previously unexpected physiological effects 
(Roth 2016; Gomez, Bonaventura et al. 2017). However, the 2 x 2 design employed provides 
control for the expression of virus alone influencing fear learning in that all animals were 
infused with AAV8-GFAP-hM4Di-mCherry and the lack of effect of CNO on the control 
freezing behavior (animals that did not receive foot shock in Context A) does provide some 
support for the specificity of CNO in this model. While we look forward to new data to 
strengthen the effect either from a control virus experiment or an experiment to test the effect 
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of hippocampal astroglial Gq signaling (for example, using AAV5-GFAP-HA-hM3Dq-IRES-
mCitrine), we are excited about our current findings which provide strong evidence for the 
involvement of hippocampal astroglial Gi signaling in SEFL.  
The current data suggest that astroglial signaling is important in the context of 
behavioral outcomes following severe stress, but the mechanism through which astroglial Gi 
signaling influences enhanced fear learning may provide greater insight into potential 
treatment targets. As has been discussed throughout the current dissertation, one potential 
mechanism through which hippocampal astroglial Gi activation might act to prevent SEFL is 
IL-1 signaling. Indeed, as mentioned previously, this hypothesis is supported by several lines 
of evidence. To directly test whether hippocampal astroglial Gi activation attenuates IL-1β 
protein and mRNA, both in stressed and naïve animals, and whether coadministration of 
recombinant IL-1β with CNO rescues the SEFL effect are important follow up experiments to 
these findings.  
Interestingly, another mechanism through which astroglial Gi activation might act in 
this context can be hypothesized from a recent report which demonstrated that Gi signaling in 
cultured primary astrocytes was associated with an increase in glial-derived neurotrophic factor 
(GDNF) and brain-derived neurotrophic factor (BDNF) (Hisaoka-Nakashima, Matsumoto et 
al. 2017).  Their data also suggest that this effect is mediated by the Fibroblast Growth Factor 
Receptor family (FGFR) as an inhibitor of FGFRs abolished the effect. Further, these data are 
consistent with an earlier report from the same laboratory which showed that amitriptyline, a 
tricyclic antidepressant, also increases GDNF through a Gi signaling pathway in astrocytes 
(Hisaoka-Nakashima, Miyano et al. 2015).  It is possible that Gi- driven astroglial release of 
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GDNF and BDNF are involved in the development of SEFL. This hypothesis is further 
supported by two lines of evidence.  
The first line of evidence to support this hypothesis is that increased BDNF has been 
shown to be protective both in terms of depressive and anxiety-like phenotypes in rodent 
models of stress and to be associated with an increase in dendritic spine density in the 
hippocampus (Lee, Shim et al. 2017; Qiao, An et al. 2017). Given that our data presented in 
Chapter 3 suggest that the severe stressor in SEFL induces a decrease in hippocampal PSD95 
immunoreactivity, an increase in BDNF and GDNF may protect against any stress-induced 
spine retraction or synaptic remodeling, that a change in PSD95 may be indicative of and, 
subsequently, protect against any stress-induced changes in memory processing that render 
animals hypersensitive to future fear learning (Berry and Nedivi 2017). The second line of 
evidence is that, as mentioned above, Xia and colleagues have shown that Fibroblast growth 
factor-2, which acts through FGFRs prevented stress-induced changes in GFAP in a model of 
single prolonged stress, another rodent model of PTSD (Xia, Zhai et al. 2013). Furthermore, 
amitriptyline, mentioned above, has been considered for and prescribed as a treatment for 
PTSD with some success (Cavaljuga, Licanin et al. 2003; Hoskins, Pearce et al. 2015) and 
attenuated a traumatic predator scent stress memory when administered 24 hours after the 
stressor (Zoladz, Fleshner et al. 2013). Collectively, these findings suggest the hypothesis that 
astroglial Gi signaling may protect against the development of PTSD-like phenotypes 
following stress, including the development of SEFL, through a GDNF and/or BDNF increase 
in the hippocampus. Future experiments should directly test these hypotheses.  
In summary, data presented in the current chapter provide strong evidence that 
astroglial Gi activation is sufficient to attenuate SEFL. The mCherry and cAMP colocalization 
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data provide strong support for the validity of GFAP-hM4Di, and we expect subsequent 
studies, including both control virus experiments to verify the specificity of CNO in this model 
and further experiments to test Gi-dependent second messengers with a larger sample size, to 
strengthen these data in the future. Nonetheless, the data presented herein suggest that, in 
addition to IL-1 signaling, astroglial GPCR signaling might represent another potential target 
for the development of novel therapeutics to treat PTSD.  
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Chapter 5 
GENERAL DISCUSSION 
Summary of findings 
The experiments presented herein provide important insights into the role of neural 
immune signaling in the development of a PTSD-like phenotype in stress-enhanced fear 
learning. Our results suggest that treatments that target neural immune signaling, including two 
specific signaling pathways, show promise to prevent the development of PTSD following a 
traumatic experience.  
Data presented in Chapter 2 confirm that dorsal hippocampal IL-1 signaling is critical 
to the development of SEFL in that dorsal hippocampal IL-1RA completely prevented 
enhanced fear learning following foot shock stress. Further analyses in Chapter 2 uncovered a 
unique effect on Iba-1 immunoreactivity, and pinpointed astrocytes as the clear predominant 
source of hippocampal IL-1β in both naïve and stressed rats. Subsequently, Chapter 3 provided 
a thorough analysis of the morphometric properties of hippocampal astrocytes 48 hours after 
exposure to the severe stressor in SEFL known to be capable of inducing a PTSD-like 
phenotype. Interestingly, while we did not detect an effect of stress on astrocyte volume, 
surface area, or colocalization with PSD95, we did detect a stress-induced reduction in 
hippocampal PSD95 immunoreactivity. The implications of this finding are discussed in 
further detail below as they related to potential insights into memory acquisition of traumatic 
vs. normal memories/experiences. Lastly, data presented in Chapter 4 suggest that  
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hippocampal astroglial Gi activation alone is sufficient to attenuate enhanced fear learning 
following foot shock in that CNO dose-dependently attenuated SEFL in AAV8-GFAP-hM4Di-
mCherry-infused rats. Importantly, we also quantified colocalization  of a Gi-dependent second 
messenger, cAMP, with virus-transduced cells and our data are the first to validate that CNO 
attenuates cAMP in AAV8-GFAP-hM4Di-mCherry-transduced cells. The implications of the 
key findings in Chapters 2 through 4 are integrated and discussed further below.  
Implications of the role of IL-1 signaling in SEFL  
The first important finding presented in Chapter 2 is that our data confirmed the critical 
role of hippocampal IL-1 signaling in SEFL (Figure 2.1). Similar to the effect of 
intracerebroventricular IL-1RA, intra-dorsal hippocampal IL-1RA completely abolished the 
PTSD-like phenotype. IL-1RA is already approved by the US Food and Drug Association and 
is marketed for the treatment of rheumatoid arthritis as Anakinra (Tarp, Furst et al. 2017). We 
argue that our data strongly suggest this drug should be explored as a potential therapeutic to 
treat human PTSD. An important follow up line of work that will be relevant to the ultimate 
application of an IL-1-specific treatment for human PTSD is to measure for how long 
hippocampal IL-1β is elevated following stress. Our early data provide evidence that the stress-
induced increase in IL-1β persists for at least 72 hours post stress (Jones, Lebonville et al. 
2015), but whether IL-1 is still elevated at the time of Context B conditioning or at later time 
points throughout testing for contextual fear to Context B and the expression of enhanced fear 
learning is unknown. Experiments to determine how long central alterations in IL-1 signaling 
persist are important given that any potential treatment to mitigate or protect against PTSD 
would be most applicable if it can be administered regardless of the time that has passed since 
the initial trauma. Of note, as mentioned above, while elevations in peripheral IL-1 do not 
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necessarily induce and/or reflect central IL-1 levels (Quan and Banks 2007), peripheral IL-1 
appears to be chronically upregulated in individuals diagnosed with PTSD (Gill, Saligan et al. 
2009; Guo, Liu et al. 2012; Gola, Engler et al. 2013; Lindqvist, Wolkowitz et al. 2014; Passos, 
Vasconcelos-Moreno et al. 2015; Wang and Young 2016). Thus, the potential use of IL-1RA 
or Anakinra in this context is well-justified by the data reported in both humans and animals 
to date.  
The mechanism through which IL-1 alters SEFL is another interesting follow up 
avenue of research. As mentioned above, research to elucidate mechanisms through which 
memories are acquired and stored is an important line of work. Long term potentiation (LTP) 
is one phenomenon that has been widely implicated in memory acquisition and learning in this 
effort (Bliss and Collingridge 1993). While it is not known how hippocampal LTP might 
directly relate to normal vs. enhanced fear learning, several groups have reported that 
hippocampal LTP is sensitive to IL-1β signaling. In an initial report, Schneider and colleagues 
showed that IL-1 signaling was critical to the maintenance, but not the induction of 
hippocampal LTP (Schneider, Pitossi et al. 1998). However, more recently, converging 
evidence suggests that there is an inhibitory effect of IL-1β application on hippocampal LTP 
(Ross, Allan et al. 2003; Prieto and Cotman 2017), with Hoshino and colleagues demonstrating 
the IL-1β-induced impairment in LTP may be synapse-specific in that IL-1β administration 
impaired the induction of LTP at some hippocampal synapses but not others (Hoshino, 
Hasegawa et al. 2017). Consistent with this, BDNF, discussed below and in Chapter 4 as a 
potential protective mechanism through which astroglial Gi might protect against SEFL, has 
been shown to facilitate LTP (Pang and Lu 2004; Bekinschtein, Cammarota et al. 2014). Future 
84 
 
studies should examine both how hippocampal LTP relates to normal vs. enhanced fear 
learning and how the involvement of IL-1 might be involved in the difference between the two.  
Implications of the role of astrocytes, and in particular astroglial Gi signaling, in SEFL   
The second important implication from the data presented in Chapter 2 is that 
hippocampal astrocytes have a critical function in SEFL. Colocalization data confirmed that 
the predominant source of hippocampal IL-1β following the severe stressor is astrocytes. 
Chapter 4 provided further evidence to support this conclusion in that hippocampal astroglial 
Gi activation alone was sufficient to attenuate SEFL. It is important to note that while intra-
dorsal hippocampal IL-1RA completely abolished SEFL such that Foot Shock in Context 
A/IL-1RA animals were not different from the No Foot Shock in Context A control animals 
(Figure 2.1), hippocampal astroglial Gi activation only partially prevented SEFL (Figure 4.3). 
Thus, follow up studies to determine how hippocampal astroglial Gi activation influences fear 
learning will provide more information regarding potential treatment targets for the 
development of novel therapeutics to treat PTSD.  
As mentioned above, an important follow up experiment is to test whether the effect of 
astroglial Gi on SEFL occurs through an IL-1-dependent mechanism. This can easily be 
achieved by co-administering recombinant IL-1β and CNO following the severe stressor in 
Context A in SEFL to determine whether supplementing hippocampal IL-1 signaling in 
combination with CNO activation of astroglial Gi signaling rescues the SEFL effect. Indeed, 
previous reports do support this hypothesis (Jin, Sato et al. 2014) (Ben Menachem-Zidon, 
Avital et al. 2011) (Cogswell, Godlevski et al. 1994) (Ye 2001). However, regardless of 
whether this hypothesis is supported, glial-derived neurotrophic factors represent another 
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potential mechanism that could be downstream of astroglial GPCR activity in the context of 
behavioral outcomes following  severe stress.   
As described above, one astroglial Gi-driven effect is an enhancement in GDNF and 
BDNF, and this is thought to occur through the activation of FGFRs (Hisaoka-Nakashima, 
Matsumoto et al. 2017). Consistent with this, both BDNF administration and FGF2 activation 
directly into the dorsal hippocampus have been shown to be protective against a PTSD-like 
phenotype (Xia, Zhai et al. 2013; Lee, Shim et al. 2017; Qiao, An et al. 2017). Strikingly, Qiao 
and colleagues showed that chronic unpredictable mild stress induced a reduction in BDNF, 
dendritic spine density, and PSD95 levels in the hippocampus and that an exogenous 
administration of BDNF rescued the stress-induced reduction in spine density and PSD95 and 
protected against the PTSD-like phenotype (Qiao, An et al. 2017).  From these data, we 
hypothesize that astroglial Gi activation in the hippocampus might attenuate SEFL by enhanced 
secretion of astroglial-derived neurotrophic factors. Further support for this hypothesis is 
described in the following section of the current chapter in that, in addition to the evidence 
reported by Qiao and colleagues, converging evidence suggests that neurotrophic factor 
secretion can influence dendrite morphology in the hippocampus (McAllister, Katz et al. 1999; 
Horch and Katz 2002; Chakravarthy, Saiepour et al. 2006; Maynard, Hobbs et al. 2017). 
Because a stress-induced reduction in PSD95 immunoreactivity, which we presented in 
Chapter 3 and discuss below, could be a reflection of stress-induced changes dendritic spine 
dynamics, a potential astroglial Gi-driven secretion of BDNF (or GDNF) that protects against 
the development of SEFL is consistent with the hypothesis discussed.  The implications for 
interpreting alterations in hippocampal spine dynamics are discussed below.  
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Lastly, we argue that, given the importance of astrocyte function in this context, 
although astrocyte morphology and synaptic contacts were not altered 48 hours post-stress, 
future studies should examine hippocampal astrocyte volume, surface area, and synaptic 
colocalization at other timepoints within SEFL. Given that most published studies examine 
astrocyte reactivity on very quick timelines following stress protocols, within 48 hours, this 
represents a significant gap in the current literature. Arguably the most interesting time point 
to examine would be the point at which animals are exposed to the subsequent fear challenge 
in Context B, the time at which hypersensitivity to future fear learning occurs.   
Implications of the effect of severe stress on PSD95 
While our primary hypothesis tested in Chapter 3 was not supported, we observed a 
stress-induced reduction in PSD95 immunoreactivity which may have implications related to 
learning and memory mechanisms in regards to dendritic spine dynamics. As discussed 
previously, PSD95 is strongly linked with stability or maturation of a given synaptic contact 
and has been linked to dendritic spine morphology and the survival of a newly formed spine 
(Ehrlich and Malinow 2004; Ehrlich, Klein et al. 2007; Taft and Turrigiano 2014) (De Roo, 
Klauser et al. 2008; Berry and Nedivi 2017).  Stability of dendritic spines has been observed 
throughout adulthood in many reports and has even been hypothesized to be a potential 
location of memory storage, however, recent reports confirm that even into adulthood a degree 
of plasticity persists and can play a role in learning (Yang, Pan et al. 2009; Lai, Franke et al. 
2012; Young, Briggs et al. 2015). Yang and colleagues used in vivo two photon imaging of 
dendritic spines in the mouse motor and sensory cortices to demonstrate that, regardless of age, 
motor learning and exposure to novel sensory experiences produce rapid dendritic spine 
formation and a portion of these persist for at least five months (Yang, Pan et al. 2009). 
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Interestingly, Lai and colleagues also reported that spine dynamics were altered by fear 
conditioning (Lai, Franke et al. 2012). Specifically, the group showed that tone-shock pairings 
were associated with dendritic spine elimination in specific areas of cortex and that the rate of 
elimination was proportional to the degree of freezing behavior. Furthermore, they showed that 
extinction training following cued fear conditioning was associated with spine formation, 
which again correlated with the decrease in the freezing behavior response. Remarkably, they 
showed that these experience-dependent changes are likely to occur on the same spines (within 
2 µm). In summary, the literature suggests that dendritic spines can be rapidly altered 
throughout learning or the encoding of an experience, and that alterations in PSD95 predict the 
stability of a given spine and could reflect such learning-dependent changes.  
The data presented herein add to the current literature to suggest that stressors capable 
of inducing PTSD-like phenotypes are associated with region-specific reductions in PSD95 in 
the hippocampus (Jianhua, Wei et al. 2017; Kumar and Thakur 2017; Qiao, An et al. 2017).  
As mentioned above, Qiao and colleagues reported a severe stress induced reduction in both 
PSD95 and dendritic spine density in the hippocampus. Similarly, Hoffman and colleagues 
observed a reduction in dendritic spine density in the dentate gyrus of the dorsal hippocampus 
following predator scent stress (Hoffman, Cohen et al. 2016).  And Serrano colleagues reported 
that social defeat stress induces changes in dendritic morphology in the hippocampus, 
including a reduction in the presence of stubby spines, which were associated with a reduction 
in the colocalization of PSD95 with the GluA2 subunit of the AMPA receptor (Iniguez, Aubry 
et al. 2016). These findings converge to suggest that dendritic spine morphology may be altered 
by severe stressors.  However, whether PSD95 tracks dendritic spine dynamics consistently in 
the context of the hippocampus and severe stress and exactly how such findings relate to 
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memory acquisition and storage and/or the intensity of the fear memory remains unknown. 
Future studies should examine whether the severe stressor in SEFL influences hippocampal 
spine density and spine morphology and, subsequently, whether such changes are related to 
and/or a component of the neuroplastic change that renders animals hypersensitive to future 
fear learning.  
Of note, while extinction learning has been thought to reflect new learning, as described 
above, there is evidence to support some degree of erasure of fear memories (Yang, Pan et al. 
2009; Lai, Franke et al. 2012). A mechanism that would allow selective erasure of fear 
memories would be an extremely valuable clinical tool to contribute to efforts to treat PTSD. 
And in this effort, experiments to better understand spine dynamics in the hippocampus 
following severe stress may be crucial. Dendritic spine plasticity is regulated by actin 
polymerization (Young, Briggs et al. 2015) and impressively, selective erasure of 
methamphetamine-associated memories has been achieved by Miller and colleagues by 
targeting the actin cytoskeleton (Young, Aceti et al. 2014; Young, Briggs et al. 2015). While 
our understanding of hippocampal spine dynamics following stress is far from such an 
endpoint, Miller and colleague’s approach may be extremely relevant if a similar mechanism 
could be identified for selective erasure of severely stressful fear memories.  
Role of additional neural immune signaling pathways in behavioral outcomes of severe 
stress 
The last section of future directions related to the experiments reported herein involve 
distinct brain regions and inflammatory signaling pathways. It is important to note that the 
hippocampus is just one brain region that is important in the prognosis of PTSD. Several 
reports have implicated other regions in PTSD development including the prefrontal cortex, 
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perirhinal cortex, and basolateral amygdala (Lopes da Silva, Witter et al. 1990; Yehuda and 
LeDoux 2007; Kealy and Commins 2011; Kent and Brown 2012; Perugini, Laing et al. 2012). 
Examining the morphology of astrocytes and/or inflammation in these areas may provide more 
information regarding mechanisms that drive the hypersensitivity to fear that is seen in SEFL. 
Indeed, there are two reports that implicate gliotransmission in the amygdala in fear learning 
(Ponomarev, Rau et al. 2010; Stehberg, Moraga-Amaro et al. 2012).  
In addition, IL-1 does not act in isolation. Several other cytokines, including IL-6, and 
TNF-α, have been shown to be dysregulated in PTSD (Gill, Saligan et al. 2009; Guo, Liu et al. 
2012; Gola, Engler et al. 2013; Lindqvist, Wolkowitz et al. 2014; Passos, Vasconcelos-Moreno 
et al. 2015; Wang and Young 2016). Further, Levkovitz and colleagues showed that 
minocycline, a general anti-inflammatory treatment prevented the development of a PTSD-
like phenotype following predator scent stress (Levkovitz, Fenchel et al. 2015). Further studies 
to examine whether the anti-inflammatory protective effect in SEFL is be specific to the IL-1 
signaling pathway or whether there are indeed other potential targets would make a significant 
contribution to this line of work.  
Summary of unanswered questions and future directions 
 The current dissertation confirmed several of our hypotheses regarding the importance 
of neural immune signaling in SEFL, specifically, hippocampal IL-1 signaling and astroglial 
signaling. However, many there are many future directions to be pursued to gain a more 
thorough understanding of this phenomenon. As mentioned previously, both how long stress-
induced enhancements in hippocampal IL-1 persist, as well as whether IL-1RA would be 
effective in attenuating SEFL if administered at later time points relative to the severe stressor 
in Context A remain unknown. Similarly, the same question is important for whether severe 
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stress alters astrocyte morphology and whether hippocampal astroglial Gi activation would also 
be effective at attenuating SEFL at the same later time points relative to Context A.  In addition, 
as mentioned above, experiments to test whether the effect of astroglial Gi activation acts 
through either an IL-1-dependent or a BDNF- and/or PSD95-related mechanism are important 
in understanding the mechanism downstream of astroglial Gi activation. Co-administration of 
CNO and recombinant IL-1β following Context A exposure in GFAP-hM4Di-mCherry-
infused rats will provide information as to whether a reduction in IL-1 signaling is required for 
the effect of hippocampal astroglial Gi activation on SEFL. And experiments to examine 
whether CNO administration in GFAP-hM4Di-mCherry-infused rats rescues any stress- 
induced deficits in BNDF or PSD95 in the dorsal hippocampus will provide information 
regarding this second hypothesized mechanism.  If reductions in PSD95 and BDNF or GFDNF 
are induced by the severe stressor and are rescued by hippocampal astroglial Gi activation, 
subsequent experiments should test the causal relationship in the context of behavioral 
consequences of stress.  
 The current literature on fear memory and anxiety/depressive-like phenotypes and our 
data presented in the current dissertation converge to support the hypotheses described above 
regarding potential stress-induced changes in dendritic spine morphology in the hippocampus. 
We argue that another important future direction will be to, independently of astroglial Gi 
activity, further describe stress-induced changes in PSD95 or dendrite morphology and test 
how these are related to either normal or enhanced fear learning following severe stress 
exposure. Experiments should test how severe stress alters dendrite morphology throughout 
SEFL, including both the 48 hours post-stress time point as well as later time points throughout 
the development and expression of SEFL. Subsequently, experiments could test whether 
91 
 
application of BDNF or GDNF rescues these deficits. Further experiments to test how these 
changes relate to freezing behavior will provide information about the causal relationship 
between hippocampal dendrite morphology and behavioral consequences of stress.  
 Lastly, we also reported a stress-induced reduction in hippocampal Iba-1 
immunoreactivity in Chapter 2. While microglial are not the focus of the current dissertation, 
and a reduction of Iba-1 in the hippocampus only strengthens our argument that astrocytes are 
indeed the key immune/support cell in this region in the context of severe stress, the reduction 
in microglia should be further explored. We are not the first for report a stress-induced 
reduction in microglia (Brzozowska, Smith et al. 2017). Furthermore, some evidence suggests 
that stress-induced changes in microglia are particularly sensitive to severity or duration of the 
stressor (Kreisel, Frank et al. 2014). Thus, while astrocyte signaling may be more important in 
the development of SEFL, a through characterization of how stress-induced changes in 
microglia are related to severity or duration of a stressor may provide insight into the 
behavioral outcomes following severe vs. more mild stress. It may be that, although reduced 
by the severe stressor at the critical time point for our effective manipulations to reduce SEFL, 
microglia are more important in more mild/ adaptive fear learning processes after a less severe 
fear or stress challenge. Indeed, the differences between memory acquisition of and behavioral 
consequences of normal vs. enhanced fear learning represent an important question, which will 
have implications that will contribute to our understanding of PTSD.  New technologies to 
study the role of microglia, including microglia-expressing DREADDs, will be able to 
contribute to this endeavor (Grace, Strand et al. 2016).  
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Concluding Remarks  
The data presented in the current dissertation demonstrate that hippocampal astrocytes 
are critically involved in SEFL and identify two signaling pathways that can be targeted to 
attenuate the development of a PTSD-like phenotype. In addition, we show that the severe 
stressor in SEFL attenuates hippocampal PSD95, which may reflect important changes in 
dendritic spine dynamics induced by severe stress that merit further study. Lastly, we show a 
CNO-specific and dose-specific effect of astroglial Gi activation on the development of SEFL 
using a glial-expressing DREADD and we are the first to confirm that, in a subset of animals, 
CNO administration attenuates the colocalization of mCherry with cAMP in AAV8-GFAP-
hM4Di-mCherry-transduced cells. Collectively, these data suggest that neural immune 
signaling is a promising target for the development of novel therapeutics to treat PTSD and 
provide insight to inform future endeavors to better understand the neurobiological 
mechanisms driving the acquisition and encoding of fear memories.  
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